Disorders of calcium metabolism

E4_CA_MET

calcium metabolic disease: Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E83.50, E83.50+F02.89, E83.50+N16.3, E83.51, E83.58, E83.59 Hospital discharge: ICD-9 — 2754 Cause of death: ICD-10 — E83.50, E83.50+F02.89, E83.50+N16.3, E83.51, E83.58, E83.59 Cause of death: ICD-9 — 2754 2 out of 7 registries used, show all original rules.	3097
4. Check minimum number of events None	3097
5. Include endpoints None	3097
6. Filter based on genotype QC (FinnGen only)	2727

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	E4_CA_MET
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E835
HD_ICD_9	2754
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E835
COD_ICD_9	2754
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of calcium metabolism based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2727	1636	1091
Unadjusted period prevalence (%)	0.55	0.58	0.50
Median age at first event (years)	65.16	64.06	66.80

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2825: Matched controls
28250

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E21.0

ICD-10 Finland

Primary hyperparathyroidism

25.0

307.7

424

198

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

34.3

307.7

293

E87.6

ICD-10 Finland

Hypokalaemia

23.5

307.7

273

128

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

32.6

307.7

395

140

A11CC03

ATC

alfacalcidol; systemic

40.3

307.7

551

169

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

27.8

307.7

252

106

Kela drug reimbursment

Hypoparathyroidism

209.4

307.7

195

A12AA04

ATC

calcium carbonate; oral

28.6

307.7

258

E83.51

ICD-10 Finland

Hypocalcemia

1216.0

307.7

908

BAA60

NOMESCO Finland

Total thyroidectomy

19.9

307.7

307

172

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

47.0

307.7

276

E83.50

ICD-10 Finland

Hypercalcemia

802.7

307.7

1686

N17.9

ICD-10 Finland

Acute renal failure, unspecified

10.2

305.7

365

404

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

7.3

293.0

474

755

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.8

263.6

1602

7270

E86

ICD-10 Finland

Volume depletion

56.6

247.9

140

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

57.1

241.3

136

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

20.9

240.4

184

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

2310.2

234.6

224

E83.58

ICD-10 Finland

Idiopathic hypercalciuria

765.7

219.0

213

C03CA01

ATC

furosemide; systemic

3.3

209.8

1287

5670

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

12.8

203.3

202

169

321

Kela drug reimbursment

Paricalcitol and cinacalcet

26.4

196.1

136

H05BX01

ATC

cinacalcet; oral

27.8

190.8

130

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.9

186.2

458

1065

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

12.0

184.7

191

170

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

18.9

178.1

142

JN4AD

NOMESCO Finland

Body CT examination

3.9

176.8

643

2004

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.0

170.8

581

1725

N18.8

ICD-10 Finland

Other chronic renal failure

10.2

165.6

191

199

N19

ICD-10 Finland

Unspecified kidney failure

7.1

158.6

252

387

E21.2

ICD-10 Finland

Other hyperparathyroidism

37.2

156.1

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

5.1

152.5

352

771

E87.5

ICD-10 Finland

Hyperkalaemia

25.0

150.1

106

M05BX04

ATC

denosumab; parenteral

4.4

148.4

421

1088

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

143.8

1699

10064

104

Kela drug reimbursment

Thyroid insufficiency

4.4

141.8

390

983

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

14.9

141.4

127

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

27.3

138.9

M04AA01

ATC

allopurinol; systemic

3.5

138.3

585

1988

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

5.9

138.3

265

490

TK800

NOMESCO Finland

Hemodialysis

10.1

138.3

160

167

EP1AE

NOMESCO Finland

Neck ultrasound examination

4.6

132.0

343

825

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.0

130.6

766

3146

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.1

128.4

677

2616

Z49.1

ICD-10 Finland

Extracorporeal dialysis

12.8

128.1

126

103

B03XA02

ATC

darbepoetin alfa; parenteral

8.4

127.5

170

213

N02AA05

ATC

oxycodone; systemic

2.9

127.1

812

3486

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

17.8

122.6

100

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.2

121.6

595

2196

H03AA01

ATC

levothyroxine sodium; systemic

2.7

121.4

917

4276

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

591.8

115.9

114

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

19.3

112.1

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

13.4

111.4

106

V03AE01

ATC

polystyrene sulfonate; oral

13.4

111.4

106

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.3

110.2

306

772

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

15.8

109.7

A11CC02

ATC

dihydrotachysterol; oral

130.7

105.8

113

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

102.5

1053

5594

BBA20

NOMESCO Finland

Exploration of parathyroid gland

39.6

101.4

AA1AD

NOMESCO Finland

CT of head and brain

2.4

99.9

1028

5451

3025

Kela drug reimbursment

Calcium carbonate

26.4

96.9

D64.9

ICD-10 Finland

Anaemia, unspecified

3.1

95.7

474

1744

127

Kela drug reimbursment

Transplant complication

10.3

94.5

107

108

JN3AD

NOMESCO Finland

Abdominal CT examination

2.9

94.0

543

2173

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

21.1

92.8

Z51.5

ICD-10 Finland

Palliative care

3.2

92.3

426

1503

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.7

91.6

590

2497

D35.1

ICD-10 Finland

Benign neoplasm: Parathyroid gland

30.6

91.2

WW500

NOMESCO Finland

Blood transfusion

4.7

91.0

222

504

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

53.0

90.7

N17.8

ICD-10 Finland

Other acute renal failure

10.8

90.5

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.8

89.5

528

2133

C90.0

ICD-10 Finland

Multiple myeloma

9.6

89.3

106

114

KA1AE

NOMESCO Finland

Kidney ultrasound examination

5.9

87.9

162

287

Z94.0

ICD-10 Finland

Kidney transplant status

12.4

87.6

L04AD02

ATC

tacrolimus; systemic

13.9

87.1

E83.59

ICD-10 Finland

Other disorders of calcium metabolism

864.1

86.1

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.4

86.0

818

4144

Z49.0

ICD-10 Finland

Preparatory care for dialysis

12.5

85.9

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

23.5

85.8

L04AA06

ATC

mycophenolic acid; systemic

8.0

84.9

117

152

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.0

84.7

428

1586

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.4

83.9

170

329

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

83.3

758

3759

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

15.0

82.0

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

8.5

80.8

105

127

A02BC02

ATC

pantoprazole; systemic

2.3

79.8

2102

15779

N18.0

ICD-10 Finland

End-stage renal disease

11.4

79.0

XW000

NOMESCO Finland

Bone marrow biopsy

4.3

78.8

215

532

137

Kela drug reimbursment

Uraemia requiring dialysis

13.3

78.7

196

Kela drug reimbursment

Paricalcitol and cinacalcet

18.1

76.8

SPAT1262

SPAT

Handing over of treatment supplies

2.5

76.7

602

2781

153

Kela drug reimbursment

Lenalidomid

13.4

76.0

WF049

NOMESCO Finland

Radiotherapy of metastasis

4.3

76.0

209

520

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.0

76.0

226

596

V03AE02

ATC

sevelamer; oral

18.3

76.0

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

76.0

872

4740

WZC00

NOMESCO Finland

Treatment plan or consultation

2.1

74.8

1207

7466

ZX120

NOMESCO Finland

Intravenous

3.0

74.2

367

1339

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

4.4

73.5

195

472

A10AB05

ATC

insulin aspart; parenteral

3.4

73.1

289

923

C08CA01

ATC

amlodipine; oral

2.1

73.0

1251

7891

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

7.9

72.8

101

132

H02AB06

ATC

prednisolone; systemic

2.0

72.8

1498

10086

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

8.4

72.5

116

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

40.6

72.3

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

11.7

71.7

R53

ICD-10 Finland

Malaise and fatigue

2.2

71.4

819

4432

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

20.0

71.3

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

5.5

70.8

141

268

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

10.7

70.3

B05DB

ATC

Hypertonic solutions

16.1

70.2

J01MA12

ATC

levofloxacin; systemic

2.3

69.5

655

3265

WZC30

NOMESCO Finland

Teaching

2.4

69.5

612

2963

L04AX04

ATC

lenalidomide; oral

12.4

69.5

V03AE03

ATC

lanthanum carbonate; oral

21.2

69.1

H03BB01

ATC

carbimazole; oral

4.4

69.0

181

434

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.8

67.2

393

1565

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

66.7

781

4244

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

11.8

65.5

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.9

65.4

147

311

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.2

65.3

746

4009

R50.9

ICD-10 Finland

Fever, unspecified

2.4

65.2

537

2518

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

9.6

64.4

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

7.7

64.2

122

329

Kela drug reimbursment

Lenalidomide

14.1

63.1

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.2

62.6

172

427

TPH07

NOMESCO Finland

Cathetrisation of artery

2.6

62.3

395

1636

A10AE04

ATC

insulin glargine; parenteral

2.9

61.8

322

1204

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

13.8

61.4

A41.9

ICD-10 Finland

Sepsis, unspecified

4.2

61.4

171

429

E20.9

ICD-10 Finland

Hypoparathyroidism, unspecified

112.6

61.1

E20.8

ICD-10 Finland

Other hypoparathyroidism

611.1

61.0

I50.9

ICD-10 Finland

Heart failure, unspecified

2.4

60.3

472

2157

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

5.1

60.2

128

258

205

Kela drug reimbursment

Chronic hypertension

2.0

60.2

843

4870

B05DA

ATC

Isotonic solutions

12.5

59.9

R11

ICD-10 Finland

Nausea and vomiting

2.9

59.2

315

1190

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.1

58.5

733

4058

Z49.2

ICD-10 Finland

Other dialysis

12.0

58.4

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

6.4

58.3

158

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

5.1

58.0

125

255

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

57.2

347

1403

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

8.0

56.7

TK810

NOMESCO Finland

Hemofiltration

16.3

56.4

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.0

55.5

122

253

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

15.1

55.4

N02AX02

ATC

tramadol; systemic, rectal

1.9

55.3

1293

8806

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

7.7

55.3

104

C07AB07

ATC

bisoprolol; oral

1.9

55.1

1448

10225

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

24.7

55.0

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.6

54.5

347

1435

E21

ICD-10 Finland

Hyperparathyroidism and other disorders of parathyroid gland

22.5

54.5

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

3.7

53.9

180

513

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

53.5

788

4601

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

53.0

786

4598

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.5

52.9

194

588

N16.3*E83.50

ICD-10 Finland

Nefrocalcinosis NEC

270.8

52.3

KH1AD

NOMESCO Finland

CT of urinary organs

3.9

52.1

159

426

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

4.0

51.9

152

395

B01AB10

ATC

tinzaparin; parenteral

2.4

51.1

398

1807

A04AA01

ATC

ondansetron; systemic, rectal

2.6

50.8

326

1352

ZXD05

NOMESCO Finland

Urgent procedure

1.9

50.7

858

5235

A10BH05

ATC

linagliptin; oral

3.3

49.9

195

615

SPAT1254

SPAT

Administration of medicine

2.2

49.5

482

2403

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

14.9

49.4

WW200

NOMESCO Finland

Immunization

4.7

49.2

116

255

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

49.1

538

2809

H02AB09

ATC

hydrocortisone; systemic

5.1

49.0

104

209

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

19.2

48.4

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

4.1

47.8

133

333

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

19.7

47.6

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.4

47.6

179

551

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

9.4

47.5

M10.9

ICD-10 Finland

Gout, unspecified

2.9

47.1

244

906

B03XA01

ATC

erythropoietin; parenteral

9.2

46.9

L28

ICPC

Limited function/disability (L)

2.0

46.9

631

3548

R06.0

ICD-10 Finland

Dyspnoea

1.9

46.8

828

5101

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

14.1

46.8

D86.0

ICD-10 Finland

Sarcoidosis of lung

6.9

46.7

106

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

4.6

46.6

113

254

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.5

46.3

162

476

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

46.2

1208

8371

J01MA02

ATC

ciprofloxacin; systemic

1.8

46.2

1135

7725

WX402

NOMESCO Finland

General anaesthesia

2.0

46.1

674

3898

A06AD11

ATC

lactulose; oral

2.1

46.0

490

2525

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

45.6

703

4136

C10AA05

ATC

atorvastatin; oral

1.8

45.6

1163

7994

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.1

44.8

195

656

N02BE01

ATC

paracetamol; systemic, rectal

2.5

44.6

2565

22542

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

44.5

402

1938

N20.0

ICD-10 Finland

Calculus of kidney

4.8

44.5

103

223

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

44.4

1770

13765

A12AA06

ATC

calcium lactate gluconate; oral

83.2

44.0

H02AB02

ATC

dexamethasone; systemic

2.2

44.0

423

2092

E55.9

ICD-10 Finland

Vitamin D deficiency, unspecified

9.8

44.0

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

5.4

43.9

168

U14

ICPC

Kidney symptom/complaint

5.2

43.7

180

UJF32

NOMESCO Finland

Coloscopy

1.8

43.4

814

5089

A10AC01

ATC

insulin (human); parenteral

2.7

42.8

238

916

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.1

42.1

119

301

ZX108

NOMESCO Finland

Inhalation

9.4

41.9

JN4BD

NOMESCO Finland

Extensive body CT

2.3

41.6

360

1703

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.0

41.6

188

R4190

NOMESCO Finland

Nutritional therapy

3.5

41.4

150

451

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

41.3

465

2441

N03AX16

ATC

[U] pregabalin

1.9

41.0

679

4071

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.3

40.8

358

1703

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.9

40.4

201

729

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

39.9

527

2926

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

13.4

39.1

UKC02

NOMESCO Finland

Cystoscopy

2.0

39.0

497

2723

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

6.5

38.9

101

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

38.8

492

2690

GD1AD

NOMESCO Finland

Thorax CT examination

2.6

38.6

239

970

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.7

38.6

215

828

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

38.3

428

2236

T90

ICPC

Diabetes non-insulin dependent

1.8

38.1

692

4256

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

38.1

1008

6909

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.4

38.0

276

1207

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

4.0

37.9

108

275

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

5.3

37.9

149

WX892

NOMESCO Finland

Monitored bed care

2.6

37.8

236

962

C08CA13

ATC

lercanidipine; oral

2.0

37.5

466

2529

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

7.5

36.9

J01DB01

ATC

cefalexin; oral

1.9

36.9

2298

19729

E61.2

ICD-10 Finland

Magnesium deficiency

101.4

36.8

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.8

36.6

198

750

C02AC05

ATC

moxonidine; oral

3.1

36.4

160

541

C10AA01

ATC

simvastatin; oral

1.7

36.0

1081

7636

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.8

35.9

110

295

N20.1

ICD-10 Finland

Calculus of ureter

3.3

35.8

140

441

KAT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pelvis of kidney

6.8

35.7

2754A

ICD-9 Finland

Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCAEMIA]

+∞

35.5

C03DA01

ATC

spironolactone; oral

2.1

35.1

372

1901

TK820

NOMESCO Finland

Peritoneal dialysis

12.2

35.0

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

35.0

508

2900

E83.39

ICD-10 Finland

Other disorder of phosphorus metabolism

351.5

35.0

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

34.9

477

2670

A28

ICPC

Limited function/disability NOS

1.9

34.9

552

3242

B01AB05

ATC

enoxaparin; parenteral

1.7

34.5

921

6291

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

34.3

254

1119

XX3DW

NOMESCO Finland

Time consuming IT work

2.1

34.1

372

1921

WW300

NOMESCO Finland

Transfer of autologic stem cells

12.8

34.0

JN6AD

NOMESCO Finland

CT of torso and neck

4.2

33.8

218

SPAT1263

SPAT

Sampling

1.6

33.6

1160

8447

C03AA03

ATC

hydrochlorothiazide; oral

2.3

33.4

289

1361

212

Kela drug reimbursment

Gout

4.6

33.4

178

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.9

33.3

158

558

E87.2

ICD-10 Finland

Acidosis

330.9

32.9

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

32.8

267

1226

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.9

32.8

254

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.2

32.7

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

9.4

32.7

A04

ICPC

Weakness/tiredness general

1.9

32.4

466

2647

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

32.3

756

4966

N20.9

ICD-10 Finland

Urinary calculus, unspecified

3.8

32.1

267

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

6.8

31.9

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

31.8

187

739

SPAT1216

SPAT

Assessment of functional ability

1.9

31.7

484

2803

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

12.0

31.7

M05BA04

ATC

alendronic acid; oral

2.1

31.4

323

1629

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

31.1

193

783

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

6.6

31.1

130

Kela drug reimbursment

Malignant tumour

2.1

30.9

301

1486

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

30.9

304

1507

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.8

30.9

265

ZX114

NOMESCO Finland

Intramuscular

5.2

30.7

123

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

30.6

189

765

SPAT1229

SPAT

Assessment of need for aid

2.3

30.5

255

1183

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

3.8

30.5

249

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

5.2

30.4

124

A10AE05

ATC

insulin detemir; parenteral

2.8

30.4

160

597

KBV00

NOMESCO Finland

Insertion of stent into ureter

8.7

30.2

B03BA03

ATC

hydroxocobalamin; parenteral

2.5

30.1

191

783

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

5.1

30.1

129

Z3231

NOMESCO Finland

Registered nurse

1.7

30.1

735

4872

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

5.0

30.0

133

A10BA02

ATC

metformin; oral

1.7

29.7

754

5045

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

9.8

29.5

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.5

29.4

192

798

N05CF01

ATC

zopiclone; oral

1.6

29.3

899

6305

N05BA04

ATC

oxazepam; oral

1.7

29.2

736

4912

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

3.9

28.8

222

N16.2*D86.8

ICD-10 Finland

Renal tubulo-interstitial disorders in sarcoidosis

294.9

28.8

C07AB02

ATC

metoprolol; systemic

1.8

28.8

557

3456

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

28.7

241

1119

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

6.3

28.7

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

28.6

552

3421

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

28.3

425

2440

SPAT1255

SPAT

Intravenous administration of medicine

2.3

28.2

218

977

E20.0

ICD-10 Finland

Idiopathic hypoparathyroidism

55.6

28.2

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

4.2

28.1

182

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

28.0

512

3123

J01FF01

ATC

clindamycin; systemic

1.7

27.9

741

5001

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

27.9

964

6939

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

27.9

900

6374

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.0

27.8

126

433

L03AA02

ATC

filgrastim; parenteral

3.1

27.8

120

401

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.8

27.1

141

523

C09AA02

ATC

enalapril; systemic

1.7

27.1

534

3326

S97

ICPC

Chronic ulcer skin

2.4

27.0

203

899

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

8.4

27.0

A06AH03

ATC

naloxegol; oral

4.3

27.0

162

E83.5

ICD-10 Finland

Disorders of calcium metabolism

273.6

26.8

E66.00

ICD-10 Finland

Metabolic syndrome

2.7

26.7

153

596

A02BC01

ATC

omeprazole; systemic

1.6

26.7

756

5177

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.6

26.6

143

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.2

26.6

108

348

ZX112

NOMESCO Finland

Subcutaneous

3.7

26.4

236

A41.8

ICD-10 Finland

Other specified sepsis

3.9

26.4

204

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.6

26.3

154

607

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

26.0

26.2

TGC00

NOMESCO Finland

Bronchial lavation

3.4

26.1

291

WX882

NOMESCO Finland

High dependency care

3.3

26.1

301

A46

ICD-10 Finland

Erysipelas

1.8

26.1

423

2483

B01AC04

ATC

clopidogrel; oral

1.9

26.1

387

2211

I50.0

ICD-10 Finland

Congestive heart failure

2.3

26.0

214

986

197

Kela drug reimbursment

Sunitinib

9.8

25.9

A02BC05

ATC

esomeprazole; systemic

1.5

25.9

1096

8227

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

4.0

25.6

182

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

25.5

229

1092

A10BB12

ATC

glimepiride; oral

2.3

25.4

192

852

K92.1

ICD-10 Finland

Melaena

2.5

25.4

168

702

E21.5

ICD-10 Finland

Disorder of parathyroid gland, unspecified

28.7

25.4

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

25.3

382

2193

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

25.3

149

589

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

8.3

25.3

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

25.1

403

2357

N03AX12

ATC

[U] gabapentin; oral

1.8

25.1

452

2737

BBA50

NOMESCO Finland

Total parathyroidectomy

58.6

25.0

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

24.9

311

1677

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

4.6

24.8

127

R4110

NOMESCO Finland

Physiotherapy

1.6

24.6

732

5056

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.3

24.5

288

L95

ICPC

Osteoporosis

2.5

24.4

160

666

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

24.4

316

1725

SPAT1234

SPAT

Support of social functional capacity

2.4

24.4

170

728

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

24.4

170

728

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

24.3

611

4047

M10.3

ICD-10 Finland

Gout due to impairment of renal function

9.7

24.1

A07AA09

ATC

vancomycin; oral

4.5

24.1

130

H02AB04

ATC

methylprednisolone; systemic

1.8

23.9

409

2436

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.3

23.9

272

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.0

23.9

110

382

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

23.8

1135

8692

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.7

23.8

131

500

L04AX01

ATC

azathioprine; systemic

2.7

23.8

134

518

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.9

23.8

183

K08.3

ICD-10 Finland

Retained dental root

2.1

23.6

236

1174

A04AA02

ATC

granisetron; systemic, transdermal

2.2

23.5

215

1033

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

23.5

1142

8776

G72.8

ICD-10 Finland

Other specified myopathies

4.3

23.5

141

C07AG02

ATC

carvedilol; oral

2.3

23.3

174

768

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.6

23.3

223

N06AX11

ATC

mirtazapine; oral

1.5

23.2

906

6642

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.1

23.1

H3603, E103,

ICD-10 Finland

8.6

22.8

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

4.3

22.6

141

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

22.6

356

2068

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

20.9

22.5

K65.0

ICD-10 Finland

Acute peritonitis

4.9

22.5

101

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

4.5

22.5

125

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.3

22.4

253

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

22.3

1897

16248

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

22.3

415

2532

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

22.2

750

5316

KA3EB

NOMESCO Finland

Antegrade pyelography

8.0

22.2

ZXA10

NOMESCO Finland

Bilateral

1.7

22.1

511

3305

N06AX16

ATC

venlafaxine; oral

1.8

22.1

361

2120

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

4.5

22.0

119

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.3

21.9

267

L04AD01

ATC

ciclosporin; systemic

3.8

21.9

180

J01MA14

ATC

moxifloxacin; systemic

2.0

21.9

259

1369

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

21.9

244

1263

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

21.8

192

908

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

21.8

498

3209

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

21.8

171

771

SPAT1310

SPAT

Counselling related to known health issue

1.5

21.8

850

6215

N30.0

ICD-10 Finland

Acute cystitis

1.7

21.8

471

2993

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

21.7

236

1210

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

21.6

440

2749

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.1

21.6

WF004

NOMESCO Finland

Palliative radiotherapy

3.2

21.5

280

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.2

21.5

190

900

D70.82

ICD-10 Finland

Drug-induced neutropenia

3.8

21.5

178

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

21.4

357

2108

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

6.4

21.4

RD210, ,

NOMESCO Finland

4.1

21.3

143

KAE12

NOMESCO Finland

Retrograde ureteronephroscopic lithotripsy in pelvis of kidney

6.6

21.3

P01AB01

ATC

metronidazole; oral, rectal

1.5

21.2

1042

7978

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

34.1

21.1

SPAT1172

SPAT

Guidance concerning hydration

3.3

21.1

248

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.2

21.0

136

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

20.9

135

558

R33

ICD-10 Finland

Retention of urine

2.1

20.7

216

1090

R31

ICD-10 Finland

Unspecified haematuria

1.9

20.7

279

1541

R13

ICD-10 Finland

Dysphagia

2.1

20.6

216

1092

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

20.6

1137

8893

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

110.9

20.6

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

8.3

20.5

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.5

20.5

203

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

20.4

724

5171

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

6.7

20.4

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.3

20.4

243

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.7

20.2

109

412

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3.0

20.1

313

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

20.1

250

1343

A12BA01

ATC

potassium chloride; oral

2.5

20.1

131

544

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.5

20.1

107

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.9

20.0

250

1345

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

18.9

19.9

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

19.8

287

1621

132

Kela drug reimbursment

Sarcoidosis

5.8

19.8

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.3

19.7

152

680

R60.0

ICD-10 Finland

Localized oedema

1.8

19.7

355

2140

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.1

19.7

189

925

C01DA14

ATC

isosorbide mononitrate; oral

1.8

19.6

350

2104

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.4

19.4

131

553

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

19.4

202

1020

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

19.3

219

1139

WX730

NOMESCO Finland

Conventional respirator

4.2

19.3

123

E66.8

ICD-10 Finland

Other obesity

2.4

19.3

136

585

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.4

19.3

201

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

19.3

210

1077

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

19.2

239

1285

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

19.2

296

1705

H02AB07

ATC

prednisone; oral

1.7

19.1

372

2292

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

19.1

494

3277

C08CA02

ATC

felodipine; oral

1.9

19.1

265

1477

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

19.1

1334

10857

B81

ICPC

Anaemia vit B12/folate deficiency

2.5

19.0

117

473

L02BA03

ATC

fulvestrant; parenteral

4.9

19.0

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.7

18.9

101

380

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.4

18.8

133

573

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.9

18.8

325

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

18.8

156

720

AA1AA

NOMESCO Finland

Head X-ray examination

4.9

18.7

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

18.7

525

3550

AN1

Coronary angiography

1.9

18.6

241

1312

M81.8

ICD-10 Finland

Other osteoporosis

4.3

18.5

110

WX002

NOMESCO Finland

Sedation and analgesia

1.6

18.5

504

3381

G47.3

ICD-10 Finland

Sleep apnoea

1.6

18.3

562

3877

N18

ICD-10 Finland

Chronic kidney disease

4.4

18.3

107

394

Kela drug reimbursment

Palbociclib

5.6

18.2

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.8

18.1

147

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

18.1

352

2165

1501

Kela drug reimbursment

Palbociclib

5.4

18.1

192

Kela drug reimbursment

Fulvestrant

5.4

18.1

ZXE00

NOMESCO Finland

One hour or less

1.4

18.0

970

7501

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.4

18.0

122

516

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.2

17.9

152

709

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

17.9

226

1221

C09CA01

ATC

losartan; oral

1.5

17.8

704

5121

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

17.8

259

1463

KBV10

NOMESCO Finland

Removal of stent from ureter

5.0

17.8

NHQ40

NOMESCO Finland

Amputation of toe

4.2

17.7

114

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.3

17.7

139

628

SPAT1301

SPAT

No procedures

1.5

17.6

824

6201

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

6.4

17.6

E0000UV, ,

ATC

1.4

17.5

1088

8623

A10BH01

ATC

sitagliptin; oral

1.9

17.5

243

1353

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

17.5

179

897

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

17.5

337

2068

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.7

17.4

345

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

4.6

17.3

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

3.1

17.2

237

SPAT1167

SPAT

Insertion of urinary catheter

2.7

17.2

347

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

6.2

17.2

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.9

17.2

130

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

17.1

367

2316

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

17.1

981

7655

H02AA02

ATC

fludrocortisone; oral

5.5

17.1

C08DB01

ATC

diltiazem; oral

2.2

17.1

145

676

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

17.1

282

1656

KBE12

NOMESCO Finland

Transluminal endoscopic extraction of calculus of ureter

4.1

17.0

113

SPAT1211

SPAT

Application of soft bandage

1.8

17.0

245

1380

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

16.0

17.0

K70.1

ICD-10 Finland

Alcoholic hepatitis

7.6

17.0

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

7.6

17.0

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.3

17.0

198

Z2446

NOMESCO Finland

Social worker

2.1

16.9

166

820

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

19.4

16.9

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

16.9

159

773

WX872

NOMESCO Finland

Intensive care

2.3

16.8

129

577

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

6.3

16.7

WVA20

NOMESCO Finland

Medicine administration

2.8

16.7

307

SPAT1260

SPAT

Consultation of another employee

1.6

16.6

463

3116

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

16.6

233

1301

N05AH04

ATC

quetiapine; oral

1.6

16.6

422

2780

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.0

16.5

243

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

5.1

16.5

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

2.4

16.3

115

495

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

16.3

339

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

5.7

16.3

OAB50, ,

SPAT

1.9

16.3

222

1229

L03AA13

ATC

pegfilgrastim; parenteral

2.2

16.2

142

670

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

6.6

16.2

N20.2

ICD-10 Finland

Calculus of kidney with calculus of ureter

5.8

16.2

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

3.1

16.1

220

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.1

16.1

220

EP1DS

NOMESCO Finland

PET-MRI of neck metabolism

30.2

16.1

105

Kela drug reimbursment

Adrenal cortical hypofunction

30.2

16.1

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.2

16.1

145

693

M10.0

ICD-10 Finland

Idiopathic gout

2.6

16.0

384

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

16.0

188

991

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.4

15.9

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

15.9

465

3164

N02BF02

ATC

pregabalin; oral

2.0

15.9

184

965

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

15.8

1000

7917

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

15.7

383

2494

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

7.2

15.7

K92.0

ICD-10 Finland

Haematemesis

2.9

15.7

256

3AC01, ,

NOMESCO Finland

4.8

15.6

C10AA04

ATC

fluvastatin; oral

1.9

15.5

198

1072

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

15.5

122

551

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

15.5

156

777

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

15.5

190

1015

A10AE06

ATC

insulin degludec; parenteral

2.6

15.5

331

GD6AD

NOMESCO Finland

CT of chest and neck

6.2

15.5

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

15.5

195

1052

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.0

15.4

221

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

15.4

102

428

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.3

15.3

170

B80

ICPC

Iron deficiency anaemia

2.8

15.3

276

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.5

15.2

393

A01

ICPC

Pain general/multiple sites

1.7

15.2

274

1649

L04AA01

ATC

[U] ciclosporin

3.6

15.2

137

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

28.8

15.2

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.8

15.2

N06AX21

ATC

duloxetine; oral

1.7

15.1

298

1838

N06AB04

ATC

citalopram; systemic

1.5

15.1

509

3568

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

15.1

553

3945

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.2

15.1

192

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.9

15.0

251

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.4

14.9

153

ZXA05

NOMESCO Finland

Left side

1.5

14.9

609

4439

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

14.8

158

805

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.3

14.8

169

A02BC03

ATC

lansoprazole; oral

1.4

14.7

730

5518

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.3

14.7

114

512

F05.9

ICD-10 Finland

Delirium, unspecified

3.0

14.7

216

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

14.7

277

1687

KAC10

NOMESCO Finland

Total nephrectomy with capsule

4.8

14.7

N03AX09

ATC

lamotrigine; oral

2.3

14.7

109

481

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

5.7

14.6

T89

ICPC

Diabetes insulin dependent

2.5

14.6

395

B01AF02

ATC

apixaban; oral

1.6

14.6

356

2318

R02

ICPC

Shortness of breath/dyspnoea

1.6

14.5

352

2288

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

3.9

14.4

105

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

14.4

153

778

C09BA02

ATC

enalapril and diuretics; systemic

1.8

14.4

204

1143

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

14.4

483

3381

D64.8

ICD-10 Finland

Other specified anaemias

3.1

14.3

193

J01EA01

ATC

trimethoprim; systemic

1.4

14.3

662

4937

GD2SN

NOMESCO Finland

Lung ventilation SPECT

5.0

14.3

R52.9

ICD-10 Finland

Pain, unspecified

1.7

14.3

264

1599

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

4.3

14.3

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

4.1

14.3

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

14.2

742

5655

N03AX14

ATC

levetiracetam; systemic

2.7

14.2

287

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.1

14.2

194

UJF92

NOMESCO Finland

Capsular endoscopy

2.9

14.2

226

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

14.2

113

514

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.5

14.1

139

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

14.1

241

1427

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.7

14.1

271

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

14.1

453

3139

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

42.7

14.1

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.4

14.1

154

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.6

14.1

300

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

14.0

754

5776

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

14.0

500

3543

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

14.0

409

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

13.9

683

5145

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

15.8

13.9

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.9

13.9

177

958

A07AA02

ATC

nystatin; oral

1.9

13.9

170

908

R06AE07

ATC

cetirizine; oral

1.4

13.9

1090

8889

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

30.2

13.9

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.8

13.9

108

XKD00

NOMESCO Finland

Uroflowmetry

1.6

13.8

389

2618

N06AB10

ATC

escitalopram; oral

1.5

13.8

452

3145

JN4CD

NOMESCO Finland

Very extensive body CT

2.2

13.8

111

507

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.9

13.8

219

N05AN01

ATC

lithium; oral

2.9

13.8

230

R55

ICD-10 Finland

Syncope and collapse

1.7

13.7

273

1687

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

5.3

13.7

WPB10

NOMESCO Finland

Making a convalescent care decision

5.3

13.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

13.7

189

1050

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.3

13.7

152

R80

ICD-10 Finland

Isolated proteinuria

5.1

13.6

M54.5

ICD-10 Finland

Low back pain

1.4

13.6

907

7198

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

13.6

231

1366

F10.24

ICD-10 Finland

Alcohol depence active use

3.7

13.6

119

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

13.6

125

603

E83.9

ICD-10 Finland

Disorder of mineral metabolism, unspecified

+∞

13.5

E20.1

ICD-10 Finland

Pseudohypoparathyroidism

+∞

13.5

XF402

NOMESCO Finland

ECG with work load test

1.7

13.5

235

1399

R42

ICD-10 Finland

Dizziness and giddiness

1.5

13.5

585

4304

C75.0

ICD-10 Finland

Malignant neoplasm: Parathyroid gland

140.7

13.5

A10AD05

ATC

insulin aspart; parenteral

3.3

13.4

149

5BA08, ,

NOMESCO Finland

5.6

13.4

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

13.3

154

807

XPX08

NOMESCO Finland

Intraoperative flow measurement

4.9

13.3

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

13.3

473

3347

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.2

13.3

160

M81.5

ICD-10 Finland

Idiopathic osteoporosis

4.1

13.3

3012

Kela drug reimbursment

Cabozantinib

13.8

13.2

1502

Kela drug reimbursment

Cabozantinib

13.8

13.2

JAH00

NOMESCO Finland

Laparotomy

2.5

13.2

340

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

4.2

13.2

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

12.2

13.1

C09AA05

ATC

ramipril; oral

1.4

13.1

596

4423

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.9

13.1

209

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

4.7

13.1

R5110, ,

SPAT

1.7

13.0

237

1429

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

13.0

208

1209

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.6

13.0

283

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

13.0

12.9

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

19.1

12.9

R79.0

ICD-10 Finland

Abnormal level of blood mineral

19.1

12.9

SPAT1097

SPAT

Recording of ECG

1.6

12.9

369

2491

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

12.9

387

SPAT1240

SPAT

Therapeutic discussion

1.7

12.9

224

1334

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.4

12.9

K29.8

ICD-10 Finland

Duodenitis

4.7

12.8

ED1AA

NOMESCO Finland

Mandibular X-ray examination

4.7

12.8

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

3.1

12.8

174

L04AX06

ATC

pomalidomide; oral

11.6

12.8

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

12.8

142

734

L01CA04

ATC

vinorelbine; systemic

3.7

12.7

110

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

3.8

12.7

101

SPAT1252

SPAT

Overall medication plan or its review

1.8

12.6

176

981

WX704

NOMESCO Finland

Intubation

1.8

12.6

203

1182

1507

Kela drug reimbursment

Pomalidomide

12.3

12.6

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

6.0

12.6

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.6

12.6

V03AG01

ATC

sodium cellulose phosphate; systemic

32.2

12.6

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.9

12.5

SPAT1325

SPAT

Vaccination

1.4

12.5

859

6830

E31.00

ICD-10 Finland

APECED syndrome

+∞

12.5

S18

ICPC

Laceration/cut

1.3

12.5

1236

10389

XG410

NOMESCO Finland

Flow-volume spirometry

2.2

12.5

104

482

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

12.5

177

992

A10BH02

ATC

vildagliptin; oral

3.0

12.5

177

C10AB05

ATC

fenofibrate; oral

3.4

12.3

132

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

3.3

12.3

137

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.0

12.3

134

688

A10AB04

ATC

insulin lispro; parenteral

2.7

12.3

256

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

5.4

12.3

L01XE04

ATC

[U] sunitinib

14.4

12.3

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

9.0

12.2

Z71.8

ICD-10 Finland

Other specified counselling

1.4

12.2

801

6318

Z3226

NOMESCO Finland

Physiotherapist

1.5

12.2

421

2956

J01CA08

ATC

pivmecillinam; oral

1.3

12.2

1020

8355

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

12.2

523

3834

M48.0

ICD-10 Finland

Spinal stenosis

1.6

12.2

325

2159

WPA13

NOMESCO Finland

Palliative consultation

4.9

12.2

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

12.1

170

949

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.1

12.1

164

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

12.1

149

798

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

12.1

302

1974

B37.08

ICD-10 Finland

Other candidal stomatitis

3.7

12.1

100

A10AB01

ATC

insulin (human); parenteral

2.6

12.1

282

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

26.8

12.0

S76

ICPC

Skin infection other

1.9

12.0

144

765

393

Kela drug reimbursment

Pomalidomide

10.1

12.0

W19

ICD-10 Finland

Unspecified fall

1.7

11.9

249

1558

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.7

11.9

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.2

11.9

102

479

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.9

11.8

143

761

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

5.4

11.8

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

3.3

11.8

131

J01CF05

ATC

flucloxacillin; systemic

1.8

11.7

172

974

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

11.7

251

1580

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.1

11.7

152

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

4.9

11.7

A03

ICPC

Fever

1.5

11.7

381

2644

160

Kela drug reimbursment

exenatide

3.0

11.6

168

R63.4

ICD-10 Finland

Abnormal weight loss

2.1

11.6

112

550

BB1AN

NOMESCO Finland

Parathyroid gland isotope imaging, 1 isotope

65.2

11.6

SPAT1104

SPAT

Monitoring of emergency patient

1.8

11.6

168

949

2522

FHL

Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)

23.0

11.6

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

11.5

192

1129

C10AX09

ATC

ezetimibe; oral

1.5

11.5

348

2376

R41.0

ICD-10 Finland

Disorientation, unspecified

2.4

11.5

344

2754B

ICD-9 Finland

Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCURIA]

+∞

11.5

WX720

NOMESCO Finland

Own respiration

2.0

11.5

120

608

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

11.4

169

960

N05BA01

ATC

diazepam; systemic, rectal

1.6

11.4

311

2074

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

4.7

11.4

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

11.4

161

902

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.2

11.4

139

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.0

11.3

121

617

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

11.3

202

1211

M10

ICD-10 Finland

Gout

2.1

11.3

110

542

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.3

11.3

365

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

11.3

172

985

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

11.3

867

6990

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

11.3

135

716

R10.0

ICD-10 Finland

Acute abdomen

2.3

11.3

378

I50

ICD-10 Finland

Heart failure

2.4

11.3

341

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

8.9

11.2

C08CA05

ATC

nifedipine; systemic

1.9

11.2

149

818

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

11.2

343

2346

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.3

11.2

392

D10

ICPC

Vomiting

2.0

11.2

118

599

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

11.2

104

504

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.0

11.2

124

641

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

11.1

406

ZXA00

NOMESCO Finland

Right side

1.4

11.1

641

4939

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

11.1

102

492

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

8.1

11.1

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.0

11.1

111

554

N07BB01

ATC

disulfiram; oral

2.2

11.1

414

T99

ICPC

Endocr/metab/nutrit disease other

3.0

11.0

168

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

11.0

467

J94.8

ICD-10 Finland

Other specified pleural conditions

2.9

11.0

179

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.4

11.0

301

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

11.0

212

1300

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

11.9

10.8

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.2

10.8

128

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.3

10.8

118

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.3

10.8

118

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.0

10.8

109

545

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

3.0

10.8

154

A10BJ06

ATC

semaglutide; parenteral

2.0

10.8

115

587

JFF13

NOMESCO Finland

Terminal enterostomy

10.6

10.8

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.0

10.7

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

10.7

130

693

2520A

ICD-9 Finland

Disorders of parathyroid gland, Hyperparathyroidism

28.1

10.7

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.5

10.7

104

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

10.7

446

R52.2

ICD-10 Finland

Other chronic pain

2.1

10.7

466

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.4

10.7

324

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

4.1

10.7

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

10.7

414

2972

J01CA04

ATC

amoxicillin; systemic

1.4

10.6

2105

19319

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

3.6

10.6

E20

ICD-10 Finland

Hypoparathyroidism

60.2

10.6

A10BK01

ATC

dapagliflozin; oral

1.7

10.6

181

1072

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

4.1

10.6

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

10.6

1107

9309

JFB00

NOMESCO Finland

Partial resection of small intestine

3.0

10.6

156

C09CA03

ATC

valsartan; oral

1.6

10.6

233

1478

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

10.6

396

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.0

10.5

151

GD1UN

NOMESCO Finland

Lung circulation SPECT

5.0

10.5

N05CD07

ATC

temazepam; oral

1.6

10.5

284

1891

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

4.5

10.5

A12AA12

ATC

[U] calcium acetate

14.2

10.5

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

14.2

10.5

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.1

10.5

141

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

10.5

143

793

C10AC01

ATC

colestyramine; oral

2.3

10.4

321

E21.4

ICD-10 Finland

Other specified disorders of parathyroid gland

110.4

10.4

N16.3

ICD-10 Finland

Renal tubulo-interstitial disorders in metabolic diseases

+∞

10.4

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.4

10.4

B01AA03

ATC

warfarin; systemic

1.4

10.4

439

3201

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

32.6

10.3

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.7

10.3

197

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.0

10.3

153

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.9

10.3

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

3.9

10.3

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

10.3

241

1551

L17

ICPC

Foot/toe symptom/complaint

1.3

10.3

754

6023

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

10.6

10.3

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

8.8

10.3

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.1

10.2

434

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.3

10.2

343

J01DA01

ATC

[U] cefalexin

1.3

10.2

1525

13421

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

10.2

167

978

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

10.2

179

1070

J02AC01

ATC

fluconazole; systemic

1.3

10.2

932

7687

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

10.2

323

2227

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.7

10.1

192

1172

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

10.1

197

1211

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

10.1

668

5253

A02BA02

ATC

ranitidine; systemic

1.4

10.1

466

3454

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

10.0

385

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

10.0

161

938

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

4.8

10.0

N21.0

ICD-10 Finland

Calculus in bladder

3.7

10.0

UKB02

NOMESCO Finland

Retrograde ureteroscopy

3.7

10.0

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

3.0

10.0

140

KCE02

NOMESCO Finland

Transluminal endoscopic extraction of calculus from bladder

4.1

10.0

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

9.9

309

2120

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

5.2

9.8

M79.7

ICD-10 Finland

Fibromyalgia

2.2

9.8

375

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

9.8

337

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.8

9.8

180

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

4.5

9.8

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

4.0

9.8

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.1

9.8

126

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

9.7

262

1742

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.3

9.7

106

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

3.7

9.7

KBT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of ureter

7.4

9.7

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.9

9.7

114

603

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

9.6

156

911

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

5.3

9.6

SAA04

NOMESCO Finland

Special examination of mouth

1.9

9.6

127

697

C10AA03

ATC

pravastatin; oral

1.8

9.6

153

889

A29

ICPC

General symptom/complaint other

1.5

9.6

337

2370

J01XX08

ATC

linezolid; systemic

4.3

9.6

C03BA11

ATC

indapamide; oral

2.3

9.6

321

L01EX07

ATC

cabozantinib; oral

11.4

9.6

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.6

9.5

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

9.5

199

1245

M79.6

ICD-10 Finland

Pain in limb

1.3

9.5

1089

9231

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.7

9.5

177

D34

ICD-10 Finland

Benign neoplasm of thyroid gland

4.0

9.5

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

9.5

1119

9522

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.1

9.5

123

SPAT1153

SPAT

Removal of sutures

1.3

9.5

805

6556

C07AA05

ATC

propranolol; systemic

1.4

9.5

461

3445

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

3.4

9.4

BBA99

NOMESCO Finland

Other operations on parathyroid gland

100.4

9.4

EBA00

NOMESCO Finland

Extraction of tooth

1.3

9.4

867

7139

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

7.5

9.4

168

Kela drug reimbursment

Axitinib

30.1

9.4

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

9.4

261

158

Kela drug reimbursment

Everolimus

17.6

9.4

BB1AQ

NOMESCO Finland

Parathyroidgland SPECT with low dose CT

+∞

9.4

E87.3

ICD-10 Finland

Alkalosis

+∞

9.4

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.5

9.4

219

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

5.2

9.4

H05BX02

ATC

paricalcitol; systemic

21.8

9.3

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

9.3

892

7380

N05BA02

ATC

chlordiazepoxide; systemic

2.4

9.3

262

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.4

9.3

H3600, E113,

ICD-10 Finland

3.4

9.3

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

3.2

9.3

109

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

4.7

9.3

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.7

9.3

185

K70.4

ICD-10 Finland

Alcoholic hepatic failure

8.7

9.3

YNB10

NOMESCO Finland

Collection of stem cells for transplant

10.7

9.3

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

9.3

176

1075

A10AA01, ,

ATC

2.7

9.2

180

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.2

9.2

372

G04CA02

ATC

tamsulosin; oral

1.4

9.2

519

3972

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

9.2

129

722

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.8

9.2

169

U04

ICPC

Incontinence urine

1.7

9.2

158

939

R03BB04

ATC

tiotropium bromide; inhalant

1.6

9.2

239

1578

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.2

9.1

321

R51.80

ICD-10 Finland

Headache

1.5

9.1

344

2452

Z31.5

ICD-10 Finland

Genetic counselling

1.9

9.1

121

666

L01EF01

ATC

palbociclib; oral

5.0

9.1

C02EA02, ,

ATC

2.0

9.1

100

517

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.1

9.1

116

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.1

9.1

116

SPAT1125

SPAT

Stoma care and guidance

2.7

9.1

176

D89.80

ICD-10 Finland

Immunoglobulin A (IgA) deposits in organisms

11.5

9.1

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

4.6

9.1

WX204

NOMESCO Finland

Axillary plexus blockaced

2.0

9.0

463

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

9.0

429

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

9.0

330

K59.0

ICD-10 Finland

Constipation

1.8

9.0

139

802

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

3.6

8.9

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

8.9

168

1023

NK6AN

NOMESCO Finland

Total body bone isotope imaging

2.1

8.9

390

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.7

8.9

166

BB1BN

NOMESCO Finland

Parathyroid gland isotope imaging, 2 isotopes

18.6

8.9

K20

ICD-10 Finland

Oesophagitis

2.6

8.9

189

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

24.1

8.9

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.2

8.9

338

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.2

8.9

338

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.7

8.9

151

895

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

8.8

103

543

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

8.0

8.8

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.4

8.8

250

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

4.9

8.8

C09DA06

ATC

candesartan and diuretics; oral

1.6

8.8

183

1144

I25.2

ICD-10 Finland

Old myocardial infarction

1.8

8.8

122

681

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

10.7

8.8

A10AB06

ATC

insulin glulisine; parenteral

3.8

8.8

R03AC02

ATC

salbutamol; inhalant

1.3

8.8

1334

11677

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

3.4

8.8

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.9

8.7

140

A10AD01

ATC

insulin (human); parenteral

2.9

8.7

140

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.0

8.7

124

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

7.2

8.7

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

8.7

145

854

WX199

NOMESCO Finland

Other local analgesia

2.0

8.7

456

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

3.6

8.7

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.0

8.7

470

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

8.7

164

1001

P01BA02

ATC

hydroxychloroquine; oral

1.6

8.6

202

1300

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

7.6

8.6

SPAT1312

SPAT

General health counselling

1.3

8.6

753

6142

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.0

8.6

125

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.8

8.6

115

635

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

4.8

8.6

A06AC51

ATC

ispaghula, combinations; oral

1.8

8.6

118

657

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

16.3

8.5

R07.3

ICD-10 Finland

Other chest pain

1.5

8.5

238

1595

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.8

8.5

J01AA02

ATC

doxycycline; systemic

1.3

8.5

2016

18595

A40.8

ICD-10 Finland

Other streptococcal sepsis

3.4

8.5

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.2

8.5

338

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.2

8.5

100

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.3

8.5

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

6.4

8.5

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

20.1

8.5

E46

ICD-10 Finland

Unspecified protein-energy malnutrition

20.1

8.5

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

8.5

1323

11602

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

8.5

114

631

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.2

8.5

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

3.7

8.4

PJA10

NOMESCO Finland

Exploration of lymph nodes

2.9

8.4

132

E85.9

ICD-10 Finland

Amyloidosis, unspecified

90.3

8.4

WX610

NOMESCO Finland

Patient controlled analgesia

3.9

8.4

N08.2

ICD-10 Finland

Glomerular disorders in blood diseases and disorders involving the immune mechanism

12.8

8.4

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

4.5

8.4

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.2

8.4

101

WZA10

NOMESCO Finland

Extensive medical or dental certificate

3.0

8.3

122

PG5ST

NOMESCO Finland

Endovascular thrombolysis of arterio-venous shunt for dialysis with radiological guidance

+∞

8.3

8010/3-C75.0

ICD-O-3

Carcinoma, NOS, of parathyroid gland

+∞

8.3

2521A

ICD-9 Finland

Disorders of parathyroid gland, Hypoparathyroidism

+∞

8.3

K85.8

ICD-10 Finland

Other acute pancreatitis

4.0

8.3

WF099

NOMESCO Finland

Other radiotherapy

4.0

8.3

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.9

8.3

491

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.5

8.3

202

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.0

8.3

117

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

8.5

8.3

A10BX04

ATC

[U] exenatide

3.6

8.3

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

8.3

161

990

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

8.3

194

1250

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

7.1

8.2

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

3.8

8.2

H25.8

ICD-10 Finland

Other senile cataract

1.5

8.2

297

2099

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

8.2

128

740

D07AA02

ATC

hydrocortisone; topical

1.5

8.2

301

2133

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

14.5

8.2

F50.9

ICD-10 Finland

Eating disorder, unspecified

4.2

8.2

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

8.2

107

587

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

8.2

106

580

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

8.2

178

1127

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.5

8.1

210

N05AH03

ATC

olanzapine; systemic

1.7

8.1

135

795

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.1

8.1

378

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

8.1

214

1418

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.2

8.1

A10BX07

ATC

[U] liraglutide

3.2

8.1

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.0

8.1

119

ZX080

NOMESCO Finland

Image guided radiotherapy

2.2

8.1

299

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.4

8.1

N25.0

ICD-10 Finland

Renal osteodystrophy

17.2

8.1

SPAT1281

SPAT

Other administrative function

1.6

8.1

179

1138

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.8

8.1

163

Kela drug reimbursment

Abiraterone and enzalutamide

3.3

8.1

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

6.8

8.1

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.7

8.0

147

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

8.0

120

686

UJD02

NOMESCO Finland

Gastroscopy

1.8

8.0

111

620

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

8.0

256

1767

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

7.2

8.0

E66.0

ICD-10 Finland

Obesity due to excess calories

3.4

7.9

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.6

7.9

171

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.1

7.9

341

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.1

7.9

348

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

7.9

105

579

M05BA07

ATC

risedronic acid; oral

2.0

7.9

430

J01FA06

ATC

roxithromycin; oral

1.3

7.9

948

8037

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.2

7.9

289

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

13.1

7.9

D86

ICD-10 Finland

Sarcoidosis

7.8

7.9

N06AA09

ATC

amitriptyline; systemic

1.5

7.9

227

1533

I50.1

ICD-10 Finland

Left ventricular failure

1.8

7.9

105

580

A10BK03

ATC

empagliflozin; oral

1.5

7.8

224

1509

WX213

NOMESCO Finland

Lower leg blockade

3.6

7.8

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

7.8

169

1067

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

2.4

7.8

214

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

7.8

183

1178

G41.9

ICD-10 Finland

Status epilepticus, unspecified

6.1

7.8

N28.1

ICD-10 Finland

Cyst of kidney

2.7

7.8

149

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.5

7.8

202

K65.9

ICD-10 Finland

Peritonitis, unspecified

8.5

7.8

F31

ICD-10 Finland

Bipolar affective disorder

3.2

7.8

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

7.8

415

3142

M86.1

ICD-10 Finland

Other acute osteomyelitis

10.8

7.8

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.0

7.8

111

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.9

7.8

503

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.6

7.8

167

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.4

7.8

215

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

7.8

180

1157

S06.0

ICD-10 Finland

Concussion

1.5

7.8

241

1653

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

7.7

468

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

7.7

159

992

A10BJ02

ATC

liraglutide; parenteral

2.2

7.7

272

N02BF01

ATC

gabapentin; oral

1.5

7.7

245

1688

M821, E2109,

ICD-10 Finland

45.1

7.7

UDC00

NOMESCO Finland

Ear microscopy

1.6

7.7

176

1127

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

15.1

7.7

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

15.1

7.7

I20.00

ICD-10 Finland

Unstable angina

2.3

7.7

247

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

2.8

7.7

139

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.2

7.7

292

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

3.9

7.7

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

2.8

7.7

128

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

5.9

7.7

A79

ICPC

Malignancy NOS

2.4

7.7

204

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.5

7.7

186

L01XE33

ATC

[U] palbociclib

4.5

7.6

WVA30, ,

SPAT

1.6

7.6

163

1027

L02BG06

ATC

exemestane; oral

2.4

7.6

223

TPH04, ,

SPAT

3.0

7.6

107

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

7.6

528

352

Kela drug reimbursment

Abiraterone and enzalutamide

4.0

7.6

N06AB06

ATC

sertraline; oral

1.5

7.6

245

1693

D12

ICPC

Constipation

1.9

7.6

500

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

25.1

7.6

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

7.6

307

2218

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.2

7.6

301

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

4.1

7.5

Z50.1

ICD-10 Finland

Other physical therapy

1.7

7.5

123

722

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.0

7.5

403

Z00.0

ICD-10 Finland

General medical examination

1.4

7.5

456

3523

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.7

7.5

119

693

207

Kela drug reimbursment

Chronic arrhythmias

1.4

7.5

375

2811

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

4.2

7.5

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.0

7.5

103

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

7.5

320

2335

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.0

7.4

384

A05AA02

ATC

ursodeoxycholic acid; oral

2.5

7.4

171

E87.7

ICD-10 Finland

Fluid overload

80.3

7.4

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.8

7.4

101

562

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

7.4

234

1611

XX2RW, ,

NOMESCO Finland

2.7

7.4

148

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

7.7

7.4

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.0

7.4

399

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.6

7.4

154

N05AX08

ATC

risperidone; systemic

1.6

7.3

191

1261

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

4.0

7.3

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.7

7.3

143

B82

ICPC

Anaemia other/unspecified

2.0

7.3

352

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.1

7.3

305

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.8

7.3

102

572

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

3.6

7.3

2581B

ICD-9 Finland

Polyglandular dysfunction and related disorders, Other combinations of endocrine dysfunction[AUTOIMMUNE-POLYENDOCRINOPATHY-CANDIDOSIS-ECTOD DYST]

+∞

7.3

WVA20, ,

SPAT

1.9

7.3

464

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

6.8

7.3

D01

ICPC

Abdominal pain/cramps general

1.4

7.3

276

1969

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

9.4

7.3

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

7.3

319

2337

A10BD07

ATC

metformin and sitagliptin; systemic

1.9

7.3

493

E000001, ,

ATC

1.3

7.2

438

3381

G72.9

ICD-10 Finland

Myopathy, unspecified

3.4

7.2

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.2

7.2

N03AF01

ATC

carbamazepine; oral, rectal

1.8

7.2

113

655

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.7

7.2

144

TPX15

NOMESCO Finland

Removal of vascular injection port

5.8

7.2

N06AX26

ATC

vortioxetine; oral

1.6

7.2

149

932

OAA67, ,

SPAT

0.6

7.2

154

2368

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.1

7.2

294

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

7.3

7.2

P15

ICPC

Chronic alcohol abuse

2.2

7.2

281

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

7.2

325

2395

ZX100, ,

SPAT

30.1

7.1

KAS40

NOMESCO Finland

Excision of transplanted kidney

30.1

7.1

4CJ01, ,

NOMESCO Finland

20.1

7.1

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

20.1

7.1

JA3FT

NOMESCO Finland

Exchange abdominal catheter with radiological guidance

20.1

7.1

C10AA02

ATC

lovastatin; oral

2.0

7.1

397

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

7.1

106

606

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

7.1

482

C09CA07

ATC

telmisartan; oral

1.6

7.1

174

1133

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.2

7.1

282

R4130

NOMESCO Finland

Speech therapy

2.2

7.1

282

322

Kela drug reimbursment

Sunitinib

7.9

7.1

K02.9

ICD-10 Finland

Dental caries, unspecified

2.5

7.1

163

M01AB01

ATC

indometacin; systemic, rectal

1.6

7.1

169

1094

ZX120, ,

SPAT

2.7

7.1

134

TGD00

NOMESCO Finland

Needle biopsy of lung

4.1

7.1

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.6

7.1

166

1071

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

6.0

7.1

J96.0

ICD-10 Finland

Acute respiratory failure

2.9

7.1

112

B74

ICPC

Malignant neoplasm blood other

8.8

7.0

JMA10

NOMESCO Finland

Transabdominal total splenectomy

4.2

7.0

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.5

7.0

176

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.0

7.0

386

QDA10

NOMESCO Finland

Incision of skin of lower limb

3.9

7.0

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.3

7.0

226

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

7.0

623

5078

L60.0

ICD-10 Finland

Ingrowing nail

1.8

7.0

108

625

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

7.0

161

1035

N05AX12

ATC

aripiprazole; systemic

2.0

7.0

352

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

4.4

7.0

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.6

6.9

147

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.5

6.9

159

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.0

6.9

XG466

NOMESCO Finland

Sleep oxymetry

2.0

6.9

346

UKA02

NOMESCO Finland

Retrograde ureteronephroscopy

5.8

6.9

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.8

6.9

119

I20.09

ICD-10 Finland

Unstable angina

1.8

6.9

106

612

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

7.5

6.9

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.6

6.9

148

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.1

6.9

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.4

6.8

178

D21

ICPC

Swallowing problem

2.5

6.8

166

M80

ICD-10 Finland

Osteoporosis with pathological fracture

3.2

6.8

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

6.8

411

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

6.8

685

5667

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

2.9

6.8

109

L29.8

ICD-10 Finland

Other pruritus

2.6

6.8

149

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.4

6.8

179

G63.8*N18.8

ICD-10 Finland

Uraemic neuropathy

40.1

6.8

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.0

6.7

377

ZY000

NOMESCO Finland

Hospital inpatient

2.9

6.7

104

J86.9

ICD-10 Finland

Pyothorax without fistula

3.1

6.7

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.2

6.7

236

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

6.7

565

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

3.9

6.7

K56.7

ICD-10 Finland

Ileus, unspecified

2.4

6.7

180

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.4

6.7

180

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

3.3

6.7

ZY010

NOMESCO Finland

Hospital outpatient

1.8

6.7

566

L01XE26

ATC

[U] cabozantinib

22.6

6.7

L29.9

ICD-10 Finland

Pruritus, unspecified

2.0

6.7

337

T92

ICPC

Gout

2.2

6.7

237

A07AA11

ATC

rifaximin; oral

6.4

6.6

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

2.9

6.6

105

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

6.6

204

1398

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

6.6

526

4220

K86.2

ICD-10 Finland

Cyst of pancreas

2.7

6.6

122

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

6.6

865

7376

7151

FHL

Kidney transplantation

12.3

6.6

K77

ICPC

Heart failure

2.2

6.6

232

WX290

NOMESCO Finland

Other blockage of nerve

1.2

6.6

1043

9081

B07.9

ICD-10 Finland

Verruca simplex

1.9

6.6

416

2505

FHL

Bilateral resection (also used if total removal has been performed on the other side)

3.5

6.6

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

1.9

6.6

452

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.3

6.5

207

NF3AA

NOMESCO Finland

Femur X-ray examination

2.1

6.5

292

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

3.8

6.5

D86.3

ICD-10 Finland

Sarcoidosis of skin

10.0

6.5

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.4

6.5

170

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

6.8

6.5

H36.01

ICD-10 Finland

Diabetic maculopathy

3.0

6.5

D07AB08

ATC

desonide; topical

1.4

6.5

236

1671

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

6.5

564

OAB42

NOMESCO Finland

Guidance related to known health problem

6.2

6.5

RS221, ,

NOMESCO Finland

2.6

6.5

135

K06.18

ICD-10 Finland

Another gingival hyperplasia

5.7

6.4

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

6.4

550

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

3.9

6.4

C09CA06

ATC

candesartan; oral

1.3

6.4

562

4563

JAH01

NOMESCO Finland

Laparoscopy

1.8

6.4

528

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

6.4

179

1201

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

70.0

6.4

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

6.4

829

7053

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

6.4

370

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.1

6.4

261

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.4

6.4

184

L04AA13

ATC

[U] leflunomide

2.1

6.4

268

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

6.4

295

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2.2

6.4

216

J05AB11

ATC

valaciclovir; oral

1.4

6.4

332

2504

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.9

6.3

400

N05CF02

ATC

zolpidem; oral

1.3

6.3

384

2964

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.2

6.3

236

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.9

6.3

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

5.2

6.3

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

5.2

6.3

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

3.1

6.3

K02.1

ICD-10 Finland

Caries of dentine

1.2

6.3

1367

12274

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

6.3

480

ZX121

NOMESCO Finland

Central venous catheter

5.5

6.3

B37.7

ICD-10 Finland

Candidal sepsis

11.0

6.3

N03.3

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis

11.0

6.3

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

9.3

6.3

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

6.3

217

1522

SPAT1138

SPAT

Guidance concerning bowel function

2.5

6.3

155

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.1

6.3

250

E79.0

ICD-10 Finland

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

18.1

6.3

XX8XW, ,

NOMESCO Finland

18.1

6.3

PJD91

NOMESCO Finland

Excision of lymph nodes in neck, 1 to 2 areas in total

18.1

6.3

L94.2

ICD-10 Finland

Calcinosis cutis

18.1

6.3

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

+∞

6.3

PB1ST

NOMESCO Finland

Thrombolysis of upper extremity artery

+∞

6.3

E85.3

ICD-10 Finland

Secondary systemic amyloidosis

+∞

6.3

M821, E8358,

ICD-10 Finland

+∞

6.3

L01XE17

ATC

[U] axitinib

+∞

6.3

N16.2

ICD-10 Finland

Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism

+∞

6.3

E83.8

ICD-10 Finland

Other disorders of mineral metabolism

+∞

6.3

HA1AA

NOMESCO Finland

X-ray mammography

1.5

6.3

205

1423

4039A

ICD-9 Finland

Hypertensive renal disease, Unspecified

26.7

6.2

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.6

6.2

126

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.7

6.2

117

716

A02BC04

ATC

rabeprazole; oral

1.5

6.2

197

1359

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

6.2

384

2973

Z29.9

ICD-10 Finland

Prophylactic measure, unspecified

3.1

6.2

S72.0

ICD-10 Finland

Fracture of neck of femur

1.7

6.2

572

SXC03

NOMESCO Finland

Other oral or dental procedure

2.8

6.2

104

K07

ICPC

Swollen ankles/oedema

1.7

6.1

117

718

Angiography of the heart and coronary arteries

1.7

6.1

108

649

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

6.1

200

1387

B04AB02, ,

ATC

2.6

6.1

127

C09DB01

ATC

valsartan and amlodipine; oral

1.9

6.1

419

H01CB03

ATC

lanreotide; parenteral

7.7

6.1

V03AA01, ,

ATC

2.6

6.1

133

C02CA01

ATC

prazosin; oral

2.4

6.1

157

C08CA10

ATC

nilvadipine; oral

2.3

6.1

201

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.0

6.1

342

Z01.2

ICD-10 Finland

Dental examination

1.2

6.1

1078

9475

C02LM02, ,

ATC

2.6

6.1

122

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.0

6.1

294

T29

ICPC

Endocr/metab/nutr sympt/compl other

2.2

6.0

234

TQW80

NOMESCO Finland

Local dermatologic skincare

2.0

6.0

315

C07AB03

ATC

atenolol; systemic

1.6

6.0

129

815

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

6.7

6.0

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

10.0

6.0

M90.7*C90.0

ICD-10 Finland

Pathological fracture in multiple myeloma

10.0

6.0

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

10.0

6.0

H04AA01

ATC

glucagon; nasal, parenteral

2.5

6.0

152

A10BJ01

ATC

exenatide; parenteral

3.2

6.0

L03AA14

ATC

lipegfilgrastim; parenteral

2.2

6.0

228

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

281

188

16.49

323.31

1.3

1.2

114.42

111.17

pmol/l

0.21

281

188

(3020630) Protein [Mass/volume] in Serum or Plasma

832

2090

5.23

319.49

4.3

2.7

65.16

66.60

g/l

4.70

768

1922

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

570

955

7.22

307.65

3.1

2.0

40.80

39.94

u/l

0.34

502

851

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

532

689

9.28

307.65

4.7

3.4

6.49

4.31

ratio

0.21

309

396

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2305

11222

6.73

307.65

22.9

5.7

1.24

1.21

mmol/l

18.29

2229

10258

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2515

12529

10.18

307.65

28.3

6.2

1.24

1.21

mmol/l

19.66

2273

10690

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1748

2914

14.11

307.65

11.4

5.1

1.04

1.03

mmol/l

0.28

1674

2700

(3004588) Protein electrophoresis panel - Serum or Plasma

763

1711

5.74

307.65

4.1

2.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

865

2019

5.73

307.65

15.3

6.2

12.88

9.54

mmol/l

27.16

837

1936

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

581

782

9.09

307.65

5.0

3.6

79.32

40.66

mg/l

0.76

487

668

(3010838) Calcium [Moles/time] in 24 hour Urine

897

365

35.54

307.65

2.8

1.9

5.51

4.86

mmol/24h

2.67

810

318

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1586

3852

8.11

307.65

6.8

3.2

0.78

0.82

mmol/l

29.95

1519

3619

(3034860) Kappa light chains.free [Mass/volume] in Serum

586

785

9.16

307.65

4.9

3.6

67.98

59.73

mg/l

0.28

492

667

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

224

42.60

307.65

1.2

4.36

13.81

pmol/l

1.40

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2222

11243

5.57

307.65

5.0

2.3

76.60

79.28

nmol/l

3.69

2121

10004

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1674

1723

22.39

307.65

6.3

3.4

86.08

85.56

ng/l

0.05

1420

1458

(3018418) pH of Serum or Plasma

1806

7363

5.03

307.65

17.7

3.7

7.40

0.50

1492

5351

(3015377) Calcium [Moles/volume] in Serum or Plasma

1884

8884

4.36

307.22

6.4

3.5

2.38

2.36

mmol/l

3.19

1746

8015

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

430

602

8.25

298.41

2.9

2.1

14.63

11.89

mg/l

3.88

385

559

(3024561) Albumin [Mass/volume] in Serum or Plasma

2111

11068

4.59

289.86

11.1

4.7

33.77

35.59

g/l

34.40

2013

10326

(3036481) Cortisol [Moles/volume] in Serum or Plasma

746

2012

4.68

257.56

2.5

2.3

387.61

371.23

nmol/l

1.15

708

1862

(3021447) Carbon dioxide [Partial pressure] in Venous blood

787

2335

4.29

238.03

9.1

3.3

5.84

5.82

kpa

0.27

768

2272

(3012544) pH of Venous blood

780

2326

4.25

233.90

9.0

3.3

7.38

0.50

526

1314

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

969

3376

3.85

232.83

5.2

2.4

21.80

22.59

0.96

910

3140

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

861

2790

4.00

229.46

5.2

4.5

262.32

247.02

u/l

1.71

822

2650

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1009

3668

3.72

226.63

5.1

2.4

2.16

2.32

g/l

14.31

950

3389

(3022948) Iron [Moles/volume] in Serum or Plasma

1052

3970

3.63

222.50

5.1

2.4

11.45

13.07

umol/l

11.82

986

3708

(3002032) Base excess in Venous blood by calculation

751

2255

4.17

221.99

9.3

3.4

2.13

1.91

mmol/l

0.64

673

1966

(3023368) Bacteria identified in Blood by Culture

1420

6708

3.25

204.36

7.7

4.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

458

988

5.34

204.18

3.9

2.4

7.47

7.30

g/l

1.02

414

904

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

457

987

5.33

203.42

3.9

2.4

3.72

3.71

g/l

0.05

413

905

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

457

988

5.33

203.18

3.9

2.4

4.11

4.22

g/l

1.33

413

906

(3009343) pH of Capillary blood

557

1482

4.44

191.53

6.4

3.6

7.42

0.25

493

1212

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

566

1535

4.36

189.68

6.5

3.6

5.10

5.16

kpa

1.01

547

1480

(3037756) Immunofixation for Serum or Plasma

315

516

6.75

187.06

2.3

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

425

932

5.19

185.16

4.0

2.4

2.91

g/l

0.00

381

850

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

511

1316

4.52

182.80

4.6

3.2

4.39

4.47

pmol/l

0.54

463

1170

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

504

1288

4.55

182.05

5.9

3.5

2.08

1.87

mmol/l

0.49

391

971

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2096

12931

3.41

181.69

11.7

6.5

10.78

11.57

umol/l

1.88

2029

12317

(3000991) Gas panel - Venous blood

635

1980

3.85

174.26

12.3

7.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

217

253

9.21

172.95

3.3

2.2

0.89

1.28

g/24h

0.71

163

135

(3018133) Calcium [Moles/volume] in Urine

113

30.14

170.71

2.5

1.8

2.75

2.82

mmol/l

0.06

106

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

571

1679

4.01

170.14

2.3

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

390

856

5.13

169.16

4.0

2.4

9.41

10.50

g/l

3.89

342

763

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

393

871

5.08

168.51

4.2

2.5

1.09

1.15

g/l

0.06

321

748

(3005719) IgG [Mass/volume] in Serum or Plasma

589

1783

3.91

168.27

4.2

3.0

10.80

10.65

g/l

0.16

547

1653

(3012565) Volume of 24 hour Urine

142

15.85

163.20

2.9

2.5

2067.41

1945.60

0.42

135

(3027945) Reticulocytes/Erythrocytes in Blood

763

2788

3.38

163.03

3.8

2.6

1.95

1.76

4.91

695

2492

(3006315) Basophils [#/volume] in Blood

1991

12343

3.08

162.31

9.2

6.1

0.04

e9/l

0.15

1784

10578

(3013115) Eosinophils [#/volume] in Blood

2030

12723

3.12

162.18

9.5

6.3

0.19

e9/l

0.44

1827

11080

(3028026) IgM [Mass/volume] in Serum or Plasma

494

1364

4.18

160.00

2.8

2.0

1.09

1.46

g/l

3.78

447

1253

(3023520) Reticulocytes [#/volume] in Blood

651

2176

3.59

159.85

3.6

2.7

69.05

67.86

e9/l

0.31

506

1596

(3001604) Monocytes [#/volume] in Blood

1981

12305

3.04

159.76

9.2

6.1

0.64

0.58

e9/l

5.24

1777

10547

(3032080) INR in Blood by Coagulation assay

1868

11247

2.95

159.57

16.6

14.5

1.20

1.26

inr

6.06

1604

9362

(42870588) Differential panel, method unspecified - Blood

1509

8189

2.81

156.29

8.9

6.3

—

(3019069) Monocytes/Leukocytes in Blood

1863

11285

2.91

155.74

9.8

6.4

8.86

8.93

0.45

1782

10521

(3024354) Oxygen [Partial pressure] in Venous blood

614

2010

3.63

155.28

7.1

2.8

4.70

4.50

kpa

1.18

592

1958

(3026493) Urate [Moles/volume] in Serum or Plasma

1249

6176

2.83

154.45

5.1

2.6

372.89

337.91

umol/l

20.47

1137

5388

(3019198) Lymphocytes [#/volume] in Blood

1998

12607

3.00

153.79

9.4

6.2

1.75

1.92

e9/l

3.87

1820

11074

(3022096) Basophils/Leukocytes in Blood

1854

11257

2.88

153.26

9.8

6.4

0.64

0.68

2.89

1768

10484

(3015235) Bicarbonate [Moles/volume] in Capillary blood

354

778

5.06

152.79

4.8

2.6

24.58

24.97

mmol/l

0.79

345

765

(3013826) Glucose [Moles/volume] in Serum or Plasma

2163

14297

3.19

152.13

10.2

4.4

6.82

6.63

mmol/l

4.09

2111

13501

(3006504) Eosinophils/Leukocytes in Blood

1851

11261

2.87

151.84

9.7

6.3

2.57

2.84

6.47

1771

10495

(3013650) Neutrophils [#/volume] in Blood by Automated count

2128

13963

3.12

151.13

16.8

9.5

4.47

4.05

e9/l

10.87

1939

12088

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

126

16.44

147.89

7.9

6.9

4.85

254.89

ug/l

0.54

(3002030) Lymphocytes/Leukocytes in Blood

1868

11541

2.83

146.47

9.7

6.3

24.52

27.81

28.29

1805

10882

(3018010) Neutrophils/Leukocytes in Blood

1839

11301

2.80

145.18

9.3

6.2

59.99

57.21

17.21

1770

10755

(21494890) Protein electrophoresis panel - 24 hour Urine

188

230

8.69

143.91

3.0

2.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1442

7876

2.70

143.81

3.8

2.5

61.66

61.49

u/l

0.02

1368

7253

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2553

18954

4.60

143.07

17.6

7.9

89.83

79.31

u/l

14.62

2504

17899

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

923

4028

2.92

142.39

2.5

1.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

405

1049

4.34

142.09

2.1

1.7

1.67

1.51

g/l

2.38

357

906

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

317

677

5.15

141.14

1.5

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1252

6446

2.69

139.59

2.9

2.3

3.24

2.89

mg/l

3.40

1112

5563

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

323

733

4.85

133.63

4.0

2.4

0.04

0.02

g/l

0.48

274

661

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

588

2050

3.36

133.06

15.1

3.3

1.25

1.23

mmol/l

1.88

554

1742

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

313

706

4.86

130.36

4.0

2.4

0.00

g/l

-0.00

254

620

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

450

1346

3.79

128.69

8.8

3.6

24.14

24.32

mmol/l

0.47

445

1334

(3004119) Hemoglobin [Mass/volume] in Venous blood

461

1407

3.72

127.93

7.4

2.7

118.77

129.17

g/l

18.13

451

1363

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

301

670

4.91

127.29

5.5

4.0

2.06

1.48

mg/l

15.06

282

605

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1054

5169

2.66

127.09

4.7

3.1

2.53

2.45

mmol/l

14.50

949

4684

(3010421) pH of Blood

319

759

4.61

124.24

7.0

3.4

7.41

1.03

313

753

(1616796) Gas panel - Central venous blood

247

473

5.63

123.93

5.8

3.9

—

(3002582) Erythrocytes [#/volume] in Urine

1401

7948

2.51

123.33

5.5

3.1

68.82

87.64

e6/l

0.30

1155

6086

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

146

159

9.63

122.15

7.3

4.4

74.30

83.33

u/ml

0.05

(3021901) Oxygen saturation in Capillary blood

233

430

5.82

121.58

4.7

2.7

90.08

90.25

0.13

228

418

(3028626) Oxygen [Partial pressure] in Capillary blood

263

544

5.23

121.05

5.2

3.3

8.15

8.30

kpa

0.67

257

534

(3023183) Ammonium ion [Moles/volume] in Plasma

231

434

5.71

118.21

3.4

2.9

34.10

35.34

umol/l

0.26

204

393

(3026008) Bacteria identified in Urine by Culture

1352

7671

2.46

117.26

4.5

3.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

349

933

4.13

116.48

2.7

1.9

2.71

2.10

ug/l

0.27

317

830

(3027273) Bicarbonate [Moles/volume] in Venous blood

368

1023

3.99

116.36

8.4

2.8

25.53

25.45

mmol/l

0.13

357

984

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

231

446

5.55

114.71

7.7

4.8

343.40

246.16

iu/ml

0.73

(3026782) Osmolality of Urine

939

4556

2.59

113.38

4.5

2.7

480.73

535.78

mosm/kgh2o

13.77

861

3977

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

279

651

4.65

111.01

4.2

2.4

0.00

g/l

-0.00

254

619

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1287

7283

2.41

110.44

2.8

2.0

266.85

216.99

u/l

0.37

1238

6848

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

696

2947

2.81

109.89

2.2

1.7

—

(3018095) Leukocytes [#/volume] in Urine

1491

9016

2.38

109.72

6.6

3.6

143.72

109.24

e6/l

0.64

1180

6372

(3022313) Gas panel - Capillary blood

368

1077

3.78

107.78

6.3

3.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

941

4669

2.52

107.37

2.4

1.5

2.69

2.48

g/l

0.77

651

2803

(3018677) aPTT in Platelet poor plasma by Coagulation assay

762

3416

2.69

107.29

2.6

2.1

29.39

29.56

0.33

739

3308

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1741

11358

2.39

106.21

4.1

2.7

—

estimate

—

(3000850) Epithelial cells [#/volume] in Urine

1060

5586

2.44

105.70

4.4

2.5

5.40

5.83

e6/l

0.54

996

5053

(3014111) Lactate [Moles/volume] in Serum or Plasma

549

2088

3.02

105.24

9.9

6.6

1.45

1.34

mmol/l

0.80

537

2052

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

442

1481

3.35

105.02

9.6

7.8

24.70

25.06

mmol/l

1.01

436

1474

(3030467) Casts [#/volume] in Urine by Automated count

1221

6877

2.37

104.37

5.1

3.0

0.63

0.41

e6/l

1.76

966

5080

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1699

11035

2.35

103.70

5.3

2.9

232.94

127.30

ug/l

12.81

1600

10216

(3003181) Sodium [Moles/volume] in Urine

161

240

7.05

103.58

2.1

1.2

59.16

67.68

mmol/l

1.33

134

184

(3016502) Oxygen saturation in Arterial blood

591

2374

2.88

102.35

8.7

7.1

94.70

95.67

1.92

572

2292

(3044640) Blood type and Crossmatch panel - Blood

1347

7966

2.32

102.09

3.8

2.4

—

(3017704) Immunofixation for Urine

113

111

10.56

101.73

1.7

—

(3019977) pH of Arterial blood

640

2706

2.76

100.38

8.5

6.9

7.41

0.67

362

1486

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

585

2364

2.86

99.98

3.0

2.3

0.20

0.21

g/l

1.99

541

2228

(3003396) Base excess in Arterial blood by calculation

634

2680

2.76

99.38

8.5

6.8

0.78

1.06

mmol/l

0.71

534

2188

(3027801) Oxygen [Partial pressure] in Arterial blood

634

2716

2.72

96.55

8.6

6.8

11.58

12.51

kpa

4.84

616

2602

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

634

2716

2.72

96.55

8.6

6.8

5.06

5.14

kpa

0.83

615

2601

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1262

7399

2.28

95.97

3.9

3.0

2829.13

1213.48

ng/l

7.57

1119

6337

(3037467) Urinalysis macro (dipstick) panel - Urine

2235

16697

2.62

95.03

7.7

4.4

—

2.79

—

(3037121) Protein [Mass/volume] in Urine

300

830

3.93

94.84

4.2

3.1

937.19

407.91

mg/l

0.59

167

334

(3002173) Hemoglobin [Mass/volume] in Arterial blood

547

2192

2.85

94.52

9.3

7.6

114.91

120.46

g/l

7.28

536

2136

(3031040) Bacteria [#/volume] in Urine by Automated count

2180

16116

2.54

94.48

7.3

4.6

3607.63

2235.56

e6/l

0.23

193

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

183

347

5.57

92.40

4.0

3.2

13486.81

1678.81

u/ml

0.43

(40768446) Kidney Pathology biopsy report

13.61

91.48

1.9

1.4

—

(3042936) Bacteria identified in Isolate by Culture

725

3400

2.52

91.12

2.7

1.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

849

4280

2.41

91.04

2.0

1.7

1283.53

1171.65

nmol/l

2.18

671

3209

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

626

2740

2.65

90.77

2.3

1.8

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2351

18179

2.75

89.80

7.0

4.4

19.23

12.32

mm/h

46.37

2242

16901

(3017181) Myelocytes/Leukocytes in Blood

549

2261

2.77

89.68

5.7

4.3

0.93

0.91

0.05

281

661

(36304419) Bacteria [Presence] in Urine

1134

6499

2.24

89.58

4.8

2.9

0.00

479.88

estimate

—

(3047189) Immunofixation for 24 hour Urine

104

112

9.60

87.55

2.8

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1457

9286

2.18

87.47

5.8

3.4

50.12

106.45

ng/l

0.60

1215

6626

(3004809) Band form neutrophils/Leukocytes in Blood

194

409

5.02

86.86

3.6

3.8

1.50

1.57

0.12

179

360

(3002179) Metamyelocytes/Leukocytes in Blood

527

2178

2.75

85.16

5.6

4.2

0.77

0.69

0.39

272

636

(3009445) Proteinase 3 Ab [Units/volume] in Serum

312

954

3.55

84.85

1.3

1.5

2.46

23.33

iu/ml

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

552

2348

2.68

84.20

2.3

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

265

730

3.90

84.03

3.7

3.0

0.30

0.35

iu/ml

1.22

135

398

(3021440) Promyelocytes/Leukocytes in Blood

524

2175

2.73

83.86

5.8

4.4

0.16

0.11

0.89

257

579

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

357

1204

3.25

83.00

8.0

3.3

47.09

47.29

0.05

345

1179

(3009508) Creatinine [Moles/volume] in Urine

1332

8327

2.13

82.53

4.9

3.2

6.45

7.42

mmol/l

15.96

1188

6921

(40767503) Oxygen content in Capillary blood by calculation

203

466

4.62

81.96

4.2

2.3

15.11

16.47

6.10

197

456

(3026250) Tacrolimus [Mass/volume] in Blood

12.01

81.84

49.0

34.2

7.18

7.15

ug/l

0.02

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

226

568

4.24

81.21

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

645

3012

2.48

80.67

2.3

1.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1201

7267

2.14

80.49

2.2

1.7

19.54

20.56

nmol/l

1.06

1043

6033

(3025159) Blasts/Leukocytes in Blood

520

2207

2.66

79.28

5.8

4.6

0.05

0.44

1.38

245

555

(4035726) Immunohistochemistry procedure

529

2273

2.63

78.62

1.6

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

127

197

6.70

78.55

2.3

1.8

6.58

3.83

mg/l

5.42

118

188

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

11.92

77.57

1.7

1.5

0.39

0.37

ug/l

0.08

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

352

1234

3.12

76.40

6.8

2.5

0.65

0.63

0.54

352

1227

(3035350) Ketones [Presence] in Urine by Test strip

1822

13042

2.12

76.29

6.0

3.9

9.46

2.09

estimate

0.72

512

2840

(3021601) Nitrite [Presence] in Urine by Test strip

1805

12881

2.11

76.12

5.9

3.8

0.00

estimate

0.50

498

2761

(3044927) Protein electrophoresis panel - Urine

137

240

5.95

75.09

1.3

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

1827

13142

2.10

74.81

6.0

3.9

0.02

0.12

estimate

0.43

487

2689

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1037

6094

2.11

73.43

3.6

2.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1610

11128

2.04

72.62

2.7

2.1

96.06

96.36

pmol/l

0.08

932

5784

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

277

865

3.44

72.58

6.5

3.8

24.94

24.91

mmol/l

0.05

263

810

(3020682) Albumin/Creatinine [Ratio] in Urine

1265

8069

2.03

70.97

6.0

3.9

33.76

6.88

mg/mmol

1.56

925

4780

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

217

588

3.91

70.17

2.3

1.8

3.80

3.68

iu/l

0.08

105

215

(3042111) Morphology [Interpretation] in Bone marrow Narrative

178

418

4.48

69.70

1.6

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

582

2772

2.38

68.53

2.2

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

674

3426

2.27

68.13

2.4

1.8

—

(3015736) pH of Urine

1496

10234

1.98

67.61

5.0

3.4

6.29

6.25

0.58

841

5719

(3012516) Albumin [Mass/volume] in Urine

1239

7950

1.99

67.32

5.0

3.3

103.23

39.27

mg/l

9.45

931

4849

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1212

7719

2.00

67.26

4.7

3.1

34.61

35.11

u/l

0.10

1151

7230

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

219

618

3.76

66.76

2.0

1.5

—

(3024928) Oxygen saturation in Venous blood

203

544

3.94

66.62

6.2

2.7

62.19

61.08

0.26

195

530

(3037522) Nuclear Ab [Titer] in Serum

644

3241

2.28

66.49

1.6

1.3

425.19

540.62

titre

1.17

135

710

(3012501) Base excess in Blood by calculation

184

461

4.20

66.19

6.0

4.0

3.09

2.67

mmol/l

1.05

143

319

(3027315) Oxygen [Partial pressure] in Blood

185

466

4.18

66.08

6.0

4.0

8.74

8.44

kpa

1.36

179

459

(3013290) Carbon dioxide [Partial pressure] in Blood

184

462

4.19

66.00

6.0

4.0

5.04

5.03

kpa

0.06

178

455

(3019225) pH of Specimen

545

2579

2.38

64.79

15.8

3.7

7.38

7.35

7.39

491

1793

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

322

1177

2.96

64.52

1.8

1.4

—

(3011985) Renin [Units/volume] in Plasma

136

274

5.16

63.99

2.4

1.3

47.93

64.58

mu/l

0.29

122

241

(3000012) Reticulocyte production index

152

337

4.71

63.88

2.2

2.3

0.81

0.89

1.02

122

226

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

255

821

3.31

63.42

2.5

2.0

680.66

603.53

ug/l

0.08

244

779

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

174

433

4.22

63.13

2.0

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

231

701

3.50

63.09

1.5

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2306

18650

2.29

63.06

7.7

4.3

15.50

14.84

pmol/l

25.56

2177

16940

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

293

1031

3.06

62.74

6.7

4.4

1.57

1.55

0.15

281

968

(3008152) Bicarbonate [Moles/volume] in Arterial blood

362

1433

2.75

62.42

8.1

6.5

24.68

24.60

mmol/l

0.10

348

1369

(3021879) Hepatitis B virus core Ab [Presence] in Serum

384

1572

2.67

61.97

1.6

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

159

378

4.40

61.22

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

329

1253

2.84

61.01

11.3

8.9

14.97

15.98

6.97

320

1196

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

556

2726

2.29

60.50

3.4

4.3

40.45

22.70

ug/l

0.81

467

2213

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

216

658

3.47

58.56

2.0

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

249

829

3.20

58.50

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1994

15462

1.98

58.09

5.1

3.2

73.98

47.27

u/l

13.08

1884

14386

(3033658) Prothrombin time (PT) actual/Normal

972

5966

1.96

57.93

7.1

3.9

90.91

89.16

1.38

951

5829

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

161

403

4.18

57.92

1.7

1.2

291.27

274.86

u/ml

0.25

101

245

(40760892) CBC W Ordered Manual Differential panel - Blood

899

5377

1.99

57.73

7.6

4.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

124

256

5.02

56.69

1.5

1.4

33.64

22.02

ng/l

0.96

124

256

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

141

326

4.50

56.21

7.7

6.3

13.30

12.00

mg/l

2.28

125

305

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

156

391

4.16

56.00

2.0

1.4

139.69

153.94

au/ml

0.65

118

(3007930) Methemoglobin/Hemoglobin.total in Blood

265

942

3.00

55.55

7.0

4.6

0.88

0.04

255

880

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

681

3731

2.09

55.48

4.8

2.9

3.07

2.76

e6/l

0.33

360

1818

(3042733) HLA Ab [Presence] in Serum

10.93

54.90

6.0

4.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

183

524

3.67

54.45

3.7

2.1

119.44

129.24

g/l

5.10

162

397

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

738

4213

2.02

53.44

4.3

2.8

1.26

1.20

e6/l

0.14

417

2305

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

166

452

3.84

53.13

2.1

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

856

5171

1.94

52.46

2.0

1.7

1.59

1.31

mg/l

1.52

681

3987

(3030981) Hyaline casts [#/volume] in Urine by Automated count

425

1968

2.36

52.24

4.3

2.2

0.42

0.47

e6/l

0.21

412

1875

(3000570) Elastase.pancreatic [Mass/mass] in Stool

226

759

3.15

52.20

1.5

1.4

247.20

278.34

ug/g

1.25

137

440

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

513

2583

2.20

51.60

5.4

3.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

17.75

51.56

17.1

9.3

4.77

5.39

mmol/l

0.89

(3019060) Gas panel - Arterial blood

338

1418

2.57

51.45

5.8

4.4

—

(3021589) Normoblasts [#/volume] in Blood

1501

10893

1.81

50.54

24.3

11.0

0.00

e9/l

0.28

1273

8926

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

241

856

2.98

50.48

2.6

2.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

336

1422

2.55

50.17

2.1

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

201

650

3.25

49.41

2.6

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

880

5470

1.88

48.77

1.4

1.3

0.99

1.60

u/ml

1.41

246

1455

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

108

226

4.93

48.58

1.3

1.2

70.43

60.03

u/l

0.54

101

196

(3002079) Sodium [Moles/time] in 24 hour Urine

8.99

48.49

1.6

1.4

161.13

160.35

mmol/24h

0.02

(40768797) Stomach Pathology biopsy report

613

3384

2.04

48.09

1.4

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

114

258

4.56

46.65

1.4

1.3

1367.94

309.29

pmol/l

0.61

219

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

853

5323

1.86

46.23

1.9

1.7

485.66

31888773.91

pmol/l

4.20

705

4406

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

106

228

4.79

46.15

2.4

25.68

28.44

iu/ml

0.13

(3017354) Segmented neutrophils/Leukocytes in Blood

119

281

4.38

46.15

3.2

3.9

64.40

56.24

3.26

106

236

(3029937) Albumin [Presence] in Urine by Test strip

1109

7514

1.78

45.69

6.1

4.0

0.00

estimate

1.60

443

2567

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

128

325

4.08

45.11

1.2

1.3

0.16

0.42

nmol/l

1.04

(3018405) Lactate [Moles/volume] in Arterial blood

219

787

2.93

44.82

4.4

3.9

1.52

1.32

mmol/l

1.01

213

782

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

125

315

4.11

44.50

1.8

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

195

662

3.09

44.11

1.6

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

316

1378

2.46

44.03

9.9

8.3

23.59

24.41

mmol/l

3.21

308

1346

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

121

303

4.13

43.44

1.9

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

157

477

3.43

42.59

1.7

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

122

312

4.04

42.57

1.2

1.3

0.66

6.31

nmol/l

0.49

117

299

(3020891) Body temperature

277

1162

2.53

41.87

7.7

4.2

36.92

36.91

°c

0.17

271

1150

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

498

2684

2.04

41.12

4.5

2.8

8.58

8.17

umol/l

0.17

424

2354

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

193

679

2.98

40.98

1.7

1.6

0.24

0.23

g/l

0.77

183

656

(3011412) CD3 cells [#/volume] in Blood

214

4.66

40.96

2.3

1076.38

1117.45

e6/l

0.17

188

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

171

565

3.16

40.47

1.7

1.4

—

(3045142) Bone marrow Pathology biopsy report

113

285

4.09

40.18

1.5

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2634

23636

2.69

40.15

39.9

14.9

26.29

24.52

mg/l

2.17

2447

19324

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

13.27

40.00

3.1

2.7

52.49

22.66

mg/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

196

705

2.91

39.98

1.7

1.6

1.16

1.18

g/l

0.29

187

681

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

192

4.81

39.57

1.8

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

7.66

39.09

3.2

2.8

0.59

0.62

mmol/l

1.15

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

140

419

3.46

38.86

1.3

391.67

389.00

titre

—

(3025941) Bacteria identified in Stool by Culture

274

1190

2.44

38.35

1.5

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

133

5.61

38.34

1.5

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

176

611

3.01

38.23

1.2

143.18

110.19

titre

0.24

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1337

9870

1.67

38.22

6.0

3.8

1.24

0.52

estimate

0.26

426

2277

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

152

486

3.25

37.97

1.7

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

135

5.52

37.74

1.5

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

173

602

3.00

37.42

1.2

1000.00

1246.32

titre

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

194

4.65

37.20

3.5

2.7

—

(3008295) Osmolality of Serum or Plasma

191

4.67

36.96

1.5

1.4

277.96

284.00

mosm/kgh2o

1.21

136

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

9.69

36.85

5.2

3.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

132

395

3.46

36.65

1.7

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

226

4.32

36.49

9.0

3.8

7.06

6.87

mmol/l

0.28

189

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

222

894

2.61

36.40

2.4

1.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

177

634

2.91

36.34

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

106

275

3.97

36.27

1.2

1.3

0.20

0.18

nmol/l

0.61

218

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

155

5.08

36.24

1.3

1.2

83.62

80.20

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

134

410

3.38

35.93

1.3

29.10

38.82

u/l

0.66

121

352

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

235

980

2.52

35.83

2.8

1.9

—

(3008037) Lactate [Moles/volume] in Venous blood

163

563

3.01

35.71

5.0

2.7

1.59

1.68

mmol/l

0.44

158

543

(40768441) Liver Pathology biopsy report

161

4.95

35.66

1.6

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

988

6837

1.68

35.42

5.6

3.3

0.72

0.31

estimate

0.30

427

2182

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

133

5.37

35.15

1.2

1.1

112.82

73.98

u/l

1.20

120

(3000494) Fungus identified in Specimen by Culture

513

2952

1.90

34.48

1.8

1.4

—

(3047181) Lactate [Moles/volume] in Blood

173

631

2.86

34.35

7.5

5.2

1.37

1.24

mmol/l

0.68

156

546

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

114

324

3.62

34.23

1.6

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

194

753

2.69

34.21

1.8

1.5

0.31

4.87

iu/ml

0.47

129

(1175426) CD3 cells/Lymphocytes in Blood

176

4.65

33.91

2.3

75.07

71.15

1.13

165

(3024522) Salmonella sp identified in Specimen by Organism specific culture

113

322

3.61

33.79

1.6

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

112

319

3.61

33.52

1.5

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2484

22085

2.03

33.10

9.3

5.2

1.95

1.94

mu/l

0.11

2360

20193

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

143

4.99

32.40

1.8

1.5

5.71

6.13

u/l

0.08

117

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

134

5.10

31.78

1.2

1.1

59.06

19.04

u/l

1.49

121

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

175

669

2.72

31.77

2.9

2.8

3.63

3.53

g/l

0.32

168

637

(3025468) Yersinia sp identified in Specimen by Organism specific culture

106

303

3.60

31.56

1.6

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

253

3.85

31.35

3.5

4.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

100

5.80

31.16

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

100

5.80

31.16

1.5

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

8.03

31.13

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

6.59

31.10

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

169

4.53

30.88

2.4

2.3

—

(3014051) Protein [Presence] in Urine by Test strip

932

6533

1.64

30.79

4.3

2.9

0.18

0.03

0.74

182

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

105

305

3.54

30.52

1.6

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

272

3.70

30.48

1.3

—

nmol/l

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

105

306

3.53

30.37

1.6

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

214

4.06

30.32

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2664

24498

2.53

30.14

47.3

17.2

139.23

139.80

mmol/l

24.12

2646

23961

(3024471) HLA-A [Type]

7.31

30.11

1.0

—

(40768804) Tissue Pathology biopsy report

1319

10093

1.58

29.90

2.5

2.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2665

24540

2.52

29.55

48.3

17.3

3.98

3.97

mmol/l

0.75

2645

23953

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

686

4487

1.70

29.39

5.3

3.5

180.06

607.38

ng/l

1.30

579

3515

(3024932) HLA-DR beta [Type]

7.26

29.26

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

167

4.40

28.60

1.8

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

180

4.25

28.51

1.8

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

158

615

2.66

27.67

2.9

3.5

1316.14

888.11

u/ml

0.17

145

569

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

8.43

27.01

4.5

3.5

—

(3003694) ABO and Rh group [Type] in Blood

934

6730

1.58

26.65

1.5

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

141

528

2.76

26.62

1.6

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

355

1960

1.93

26.58

2.7

2.1

4.99

7.12

ug/l

2.95

304

1725

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

127

451

2.90

26.47

1.4

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

200

3.93

26.34

1.1

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

157

4.35

26.28

1.9

1.5

—

(3017732) Neutrophils [#/volume] in Blood

508

3143

1.75

26.28

3.9

3.0

4.72

4.47

e9/l

0.38

424

2708

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

9.77

25.90

1.4

1.7

—

(3042631) Mycobacterium sp identified in Specimen

104

335

3.18

25.68

2.2

2.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

297

1562

2.01

25.57

1.2

177.46

131.83

u/ml

0.78

116

572

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

154

616

2.59

25.52

1.7

1.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

361

2031

1.89

25.48

4.7

2.5

47.60

66.26

ml/min/173m2

16.40

208

830

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

154

4.30

25.15

1.9

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

490

3040

1.74

24.99

2.5

2.3

155.87

134.88

ug/g

0.84

402

2369

(3010375) cycloSPORINE [Mass/volume] in Blood

5.29

23.91

25.6

26.4

95.39

120.29

ug/l

1.88

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

219

3.63

23.89

2.2

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

219

3.63

23.89

2.2

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

219

3.63

23.89

2.2

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

9.15

23.85

1.5

1.1

—

(3004451) EKG impression Narrative

119

4.69

23.83

1.5

1.3

—

(40758558) Short blood count panel - Blood

998

7442

1.53

23.77

10.9

6.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

5.18

23.35

2.3

1.9

40.13

27.85

3.65

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

5.24

23.15

2.7

1.9

37.67

40.54

g/l

2.01

(44816559) Phosphatidylethanol [Mass/volume] in Blood

184

838

2.28

22.92

2.3

1.6

0.43

0.32

mg/l

1.41

374

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

100

4.97

22.75

3.7

3.0

1.21

1.44

0.41

100

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

281

3.24

22.73

2.1

1.6

—

(40761536) Microorganisms panel - Urine sediment

352

2045

1.82

22.29

6.4

3.8

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

139

4.24

22.13

2.1

2.2

0.50

0.66

e9/l

1.54

132

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

375

2239

1.78

21.65

3.8

2.5

42.78

60.72

u/l

0.38

324

1877

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1619

13495

1.47

21.32

3.4

2.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

810

5911

1.52

20.74

5.2

3.8

1.40

0.79

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

142

4.08

20.68

2.3

2.6

511.49

482.45

e6/l

0.13

114

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

203

3.51

20.46

1.8

1.5

—

(40768795) Lymph node Pathology biopsy report

268

3.16

20.46

1.5

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

344

2.88

20.31

1.9

2.3

53.70

1296.11

u/ml

0.85

339

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

6.10

20.30

1.9

1.4

14.86

15.89

pmol/l

0.54

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

259

3.19

20.29

2.1

1.6

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2497

22964

1.75

19.97

37.7

14.6

69.54

79.05

ml/min/173m2

59.61

2412

21287

(3035933) Granulocytes/Leukocytes in Blood

129

534

2.48

19.92

5.1

3.2

60.94

57.60

2.06

129

534

(36660697) Celiac disease serology panel - Serum

320

1869

1.80

19.82

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

134

4.09

19.71

2.9

2.8

37.43

41.09

0.68

(3045424) Erythrocytes [Presence] in Urine

243

1303

1.95

19.66

3.0

2.1

0.00

0.64

estimate

0.50

391

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

109

419

2.67

19.60

3.4

1.9

1.11

0.82

nmol/l

2.55

351

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

8.40

19.26

1.0

1.1

—

(3016750) Collection duration of Urine

111

4.38

19.20

3.6

2.0

500.28

479.97

min

0.58

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

6.73

19.13

1.2

1.4

—

(3004775) Volume in Urine collected for unspecified duration

155

3.80

19.13

3.2

2.1

748.84

643.84

0.94

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

116

468

2.54

18.92

3.6

2.2

199.94

104.14

ug/min

0.75

260

(3014148) Varicella zoster virus Ab [Titer] in Serum

260

3.10

18.88

1.1

—

(3039000) Anion gap in Blood by calculation

111

440

2.59

18.77

9.7

6.0

11.81

11.14

mmol/l

1.16

102

383

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

148

3.84

18.76

2.6

191.11

211.10

e6/l

0.33

128

(3018572) Chloride [Moles/volume] in Blood

111

441

2.58

18.69

9.7

6.0

105.24

105.26

mmol/l

0.02

102

384

(3023420) DNA double strand Ab [Units/volume] in Serum

194

980

2.05

18.57

1.8

7.89

7.91

iu/ml

0.00

226

(3022145) Colonoscopy Study observation

442

2872

1.64

18.51

1.5

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

126

534

2.42

18.51

1.6

1.4

14.78

10.88

u/l

1.45

100

433

(21494434) Karyotype in Bone marrow

227

3.23

18.48

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

387

2433

1.68

18.41

2.1

1.8

1.70

1.47

5.20

320

2133

(3036489) Thrombin time

170

822

2.14

18.27

2.3

2.2

21.15

20.95

0.26

155

723

(3024980) IgG subclass 4 [Mass/volume] in Serum

380

2.66

17.87

1.5

1.7

0.81

0.86

g/l

0.13

301

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

123

4.04

17.64

2.5

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

123

4.04

17.64

2.5

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

123

4.04

17.64

2.5

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

123

4.04

17.64

2.5

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

323

2.78

17.33

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

138

627

2.26

17.30

2.5

2.7

219.17

189.29

2.81

130

592

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

302

2.84

17.19

1.1

1.70

1.50

g/l

3.18

268

(3017569) Oxygen content in Arterial blood

122

3.99

17.00

2.7

2.6

14.50

15.97

1.70

122

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

182

938

2.01

16.48

2.4

3.6

1108.05

1700.06

u/ml

0.19

159

799

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

141

662

2.19

16.33

1.8

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

258

2.92

16.03

1.3

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

332

2.67

15.92

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

119

3.91

15.91

2.5

2.1

7.69

8.59

mmol/l

0.69

119

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

173

3.34

15.60

1.3

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

132

616

2.20

15.53

2.0

1.6

333.97

289.34

mu/l

0.85

119

572

(3026389) Candida sp identified in Specimen by Organism specific culture

325

2.67

15.50

1.9

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

38.26

15.38

6.1

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

155

3.47

15.36

1.7

1.3

0.74

1.20

promille

1.38

123

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

621

4527

1.48

15.24

1.4

1.3

47.49

34.87

iu/ml

0.84

196

1345

(44790048) Parainfluenza type 2 nucleic acid detection

305

2.70

15.22

1.8

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

305

2.70

15.22

1.8

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

305

2.70

15.22

1.8

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

305

2.70

15.22

1.8

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.36

15.22

2.1

2.4

951.50

2522.46

u/ml

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

117

524

2.29

15.20

1.3

1.4

3.95

3.67

mmol/l

1.52

110

492

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2667

25329

1.95

14.97

50.9

19.6

103.40

76.42

umol/l

55.92

2653

24984

(3002256) Pathology report gross observation

495

3458

1.52

14.92

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

237

1378

1.79

14.81

3.1

3.8

56.21

80.85

u/ml

0.81

230

1328

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

112

499

2.30

14.74

1.8

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

222

2.97

14.64

1.5

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

127

601

2.17

14.45

1.3

1.4

471.64

576.72

mg/l

2.12

121

567

(37021550) Renin [Units/volume] in Plasma --upright

6.00

14.32

1.7

1.3

204.28

47.32

mu/l

0.90

(3036525) Urea [Moles/time] in 24 hour Urine

27.31

14.26

2.4

2.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

298

1875

1.66

13.98

3.8

2.8

268.45

194.60

ng/l

1.09

272

1704

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

104

460

2.31

13.93

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

104

460

2.31

13.93

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

174

938

1.91

13.84

1.3

1.2

0.31

1.12

u/ml

1.24

(3014271) Vancomycin [Susceptibility]

4.00

13.61

3.6

2.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.00

13.61

2.7

1.8

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

232

2.84

13.55

1.3

1.4

7.20

6.72

g/l

0.33

170

(3028192) IgG subclass 2 [Mass/volume] in Serum

232

2.84

13.55

1.3

1.4

2.79

3.02

g/l

0.36

172

(3024139) IgG subclass 3 [Mass/volume] in Serum

232

2.84

13.55

1.3

1.4

0.50

0.41

g/l

0.30

169

(3027570) Oxalate [Moles/time] in 24 hour Urine

16.27

13.44

1.8

1.4

316.24

320.69

umol/24h

0.03

(3024666) Lithium [Moles/volume] in Serum or Plasma

106

3.81

13.42

15.9

13.4

0.74

0.64

mmol/l

2.09

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

572

4198

1.45

13.35

1.4

1.3

9.96

11.80

u/ml

0.31

210

1610

(3034988) Calcium [Moles/volume] in Capillary blood

6.33

13.28

2.0

1.6

1.19

1.18

mmol/l

0.12

(4062490) Immunoglobulin typing, IgG

224

2.85

13.23

1.3

1.4

—

(3049717) Cytology report of Urine Cyto stain

165

888

1.91

13.20

2.3

2.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

151

3.28

13.13

1.1

—

(3045414) Leukocytes [Presence] in Urine

372

2506

1.56

13.12

2.8

2.0

0.04

0.02

estimate

0.42

483

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

347

2.46

13.12

1.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2635

25051

1.77

13.01

23.5

11.8

25.18

25.46

u/l

0.36

2593

24221

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.93

12.98

2.7

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.93

12.98

2.7

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

124

617

2.06

12.41

2.0

1.6

15124.96

11291.39

e6/l

0.53

428

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.55

11.88

1.5

1.2

93.89

176.71

nmol/24h

0.38

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

157

3.09

11.70

1.9

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

354

2.36

11.66

1.5

1.4

33.01

32.76

g/l

0.06

325

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.85

11.63

1.3

3.9

4778.48

67.56

mg/l

0.49

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

278

2.52

11.41

1.3

1.4

32.40

28.72

u/l

0.30

234

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

377

2.29

11.37

1.2

1.05

1.11

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

215

2.73

11.32

1.9

1.5

418.24

327.11

mu/l

0.80

170

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

194

1153

1.73

11.24

1.1

1.18

0.91

u/ml

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

4.93

11.20

1.2

434.05

272.11

pmol/l

0.63

(3019150) Specific gravity of Urine by Refractometry

733

5768

1.37

11.18

5.9

4.1

1.02

1.28

kg/l

0.50

526

3765

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

104

505

2.10

11.14

1.5

1.6

15.81

27.97

e6/l

0.32

377

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

105

513

2.09

11.07

1.5

1.6

383.28

1002.56

e6/l

0.85

404

(3044290) Cell count panel - Cerebral spinal fluid

100

484

2.11

10.81

1.4

1.5

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

21.53

10.67

1.2

1.1

29.97

45.66

mg/24h

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

125

3.23

10.54

1.2

1.3

22.60

6.12

u/l

0.45

110

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.71

10.41

1.4

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

9.58

10.24

4.2

2.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

134

735

1.86

10.16

1.4

1.2

50.11

32.52

u/ml

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

4.22

10.09

2.0

1.6

4614.73

29536.74

e6/l

0.44

(3028433) Virus identified in Specimen by Culture

3.78

10.03

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

114

3.28

9.99

2.6

2.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

249

2.48

9.86

2.0

1.5

—

2512.00

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

158

2.88

9.75

1.2

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

341

2.23

9.52

1.2

1.1

23.46

92.13

iu/ml

1.16

(3035947) Staphylolysin Ab [Units/volume] in Serum

3.55

9.49

1.1

—

4.40

iu/ml

—

(40765096) Chromosome analysis panel by Banding

3.47

9.46

1.3

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

161

2.82

9.43

1.2

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

118

637

1.89

9.42

1.3

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

21.76

9.34

1.5

1.3

2.12

1.85

mmol/24h

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

118

639

1.88

9.33

1.3

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

236

1548

1.57

9.30

1.8

1.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.69

9.29

2.0

2.3

10.29

9.93

kpa

0.14

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.69

9.29

2.0

2.3

5.54

5.26

kpa

0.30

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

106

555

1.95

9.28

2.1

2.0

5680.06

4467.01

u/l

0.12

226

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

9.53

9.26

7.4

3.9

—

(3000060) B lymphocytes [#/volume] in Blood

4.06

9.24

1.9

2.9

0.31

0.24

e9/l

—

(3023199) Leukocytes [#/volume] in Pleural fluid

307

2.28

9.23

1.5

1.4

1730.24

2374.91

e6/l

0.49

212

(3027923) C peptide [Moles/volume] in Serum or Plasma

120

3.11

9.21

1.7

1.4

1.29

1.15

nmol/l

0.31

(42529406) Shigella sp [Presence] in Stool by Culture

118

642

1.87

9.20

1.3

1.2

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2093

19331

1.32

9.19

46.0

18.4

14.34

13.65

70.24

2085

19033

(3012441) Differential panel - Pleural fluid

258

2.39

9.16

1.5

—

(3023419) Bacteria identified in Sputum by Culture

334

2.22

9.14

2.3

2.5

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

277

2.34

9.13

2.0

1.6

71.48

57.22

2.31

169

(3052851) Hemolysis interference index of Serum or Plasma

114

616

1.89

9.09

4.7

3.2

3.12

1.94

index

0.63

315

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

133

2.96

8.92

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

133

2.96

8.92

1.4

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

198

1261

1.61

8.84

2.7

2.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.52

8.79

1.2

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.79

8.78

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.57

8.67

2.5

3.0

183.30

151.02

umol/l

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.26

8.62

1.2

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

125

2.99

8.61

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

8.23

8.56

2.1

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

106

571

1.89

8.55

5.5

4.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

20.08

8.46

4.3

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

123

698

1.80

8.41

1.4

1.3

2.88

4.45

u/ml

0.89

117

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

106

578

1.87

8.25

1.3

1.2

1.06

4.22

u/ml

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

215

2.45

8.23

1.2

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

113

3.03

8.15

1.2

128.09

138.50

nmol/l

0.67

113

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.37

8.14

1.3

—

(4146454) Self-monitoring of blood glucose

241

2.35

8.13

3.3

2.5

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

4.55

8.11

1.1

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

135

2204

0.59

8.10

2.0

3.60

3.45

ratio

0.68

116

1736

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

242

2.34

8.06

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

22.08

8.01

3.2

5.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

121

695

1.77

7.96

1.4

1.3

2.84

2.46

u/ml

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2383

22565

1.36

7.87

9.2

6.0

40.79

38.87

mmol/mol

17.75

2203

20838

(3035880) pH of Pleural fluid

132

2.83

7.85

1.4

1.3

7.39

7.41

0.20

(3007461) Platelets [#/volume] in Blood

2668

25798

1.62

7.84

57.1

23.0

253.08

250.09

e9/l

1.24

2644

25242

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2668

25802

1.61

7.79

56.9

22.9

91.69

91.31

3.71

2655

25468

(3004616) Nuclear Ab [Presence] in Serum

317

2.14

7.78

1.4

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

134

798

1.71

7.78

1.7

—

(3035941) MCH [Entitic mass]

2668

25803

1.61

7.78

56.8

22.9

30.26

30.35

1.79

2655

25467

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2426

23047

1.37

7.76

6.5

5.1

6.14

5.89

mmol/l

13.45

2209

20911

(3026361) Erythrocytes [#/volume] in Blood

2668

25805

1.61

7.75

57.0

23.0

4.22

4.47

e12/l

84.76

2640

25156

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2668

25805

1.61

7.75

58.1

23.3

38.09

40.21

73.94

2654

25456

(3010813) Leukocytes [#/volume] in Blood

2668

25806

1.61

7.73

57.1

23.0

7.22

6.69

e9/l

20.03

2641

25147

(3000963) Hemoglobin [Mass/volume] in Blood

2668

25810

1.61

7.68

57.5

23.1

126.10

134.68

g/l

120.52

2655

25485

(40768806) Pleura Pathology biopsy report

268

2.23

7.58

1.5

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

120

2.86

7.37

1.1

1.0

0.95

1.17

u/l

2.11

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1613

0.56

7.21

1.8

3.57

3.47

mmol/l

0.34

1140

(3045788) Cell count panel - Pleural fluid

255

2.22

7.17

1.3

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

111

2.90

7.16

1.0

1.1

1527.44

1474.88

miu/ml

0.09

111

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

106

2.95

7.12

2.9

4.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

169

2.51

7.09

1.0

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

277

2.15

7.02

1.4

13219.06

70311.33

e6/l

1.15

147

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

118

2.82

7.00

1.0

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

411

3159

1.35

6.98

12.1

6.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

325

2.06

6.94

1.3

1.2

2.04

3.43

u/ml

1.92

142

(3023487) Leukocytes [#/volume] in Peritoneal fluid

3.27

6.83

2.0

1.9

1442.14

721.78

e6/l

0.31

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

185

2.40

6.78

1.3

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

527

1.81

6.76

4.0

3.3

0.84

0.80

nmol/l

0.35

429

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

111

657

1.72

6.63

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

238

2.21

6.60

1.8

1.4

119490.14

37705.13

e6/l

0.54

165

(40759836) Histone Ab [Presence] in Serum by Immunoblot

182

2.38

6.54

1.3

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

260

2.14

6.46

1.1

—

5.37

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.30

6.41

1.2

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

532

1.77

6.28

1.3

1.2

46.29

39.85

u/ml

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

389

1.90

6.18

1.9

1.8

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

176

2.35

6.07

1.3

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.60

6.03

1.2

1.4

26.32

27.30

g/l

0.07

(3009466) Valproate [Moles/volume] in Serum or Plasma

295

2.02

6.00

6.2

5.5

350.42

356.77

umol/l

0.12

259

(3003329) Lymphocytes/Leukocytes in Synovial fluid

223

2.17

5.91

2.0

1.5

21.53

30.61

1.31

133

(3006576) Bicarbonate [Moles/volume] in Blood

3.79

5.81

6.5

5.1

24.61

24.38

mmol/l

0.06

(3028707) Methadone [Presence] in Urine by Screen method

258

2.07

5.81

1.7

2.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

181

2.28

5.71

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

181

2.28

5.71

1.3

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

253

2.08

5.71

1.3

1.6

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

3.41

5.58

1.9

1.3

16.58

36.03

1.96

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

135

881

1.56

5.53

1.5

1.6

27.92

14.99

u/ml

1.56

183

(3008536) Aspergillus sp Ab [Presence] in Serum

3.48

5.45

1.8

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.24

5.44

1.6

1.2

13.63

13.60

g/l

0.00

(3001218) Citrate [Mass/time] in 24 hour Urine

16.04

5.41

1.0

1.6

498.62

375.00

mg/24h

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.03

5.37

1.1

92.00

86.77

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

331

1.89

5.27

1.2

3.43

4.43

u/ml

0.21

120

(3023323) Follitropin [Units/volume] in Serum or Plasma

140

934

1.52

5.21

1.6

1.4

29.78

28.77

iu/l

0.12

115

808

(3005322) IgE [Units/volume] in Serum or Plasma

213

1543

1.41

5.20

1.4

1.3

160.01

204.07

u/ml

0.59

199

1436

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

126

2.48

5.20

1.3

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

7.36

5.14

1.1

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

309

1.90

4.98

1.3

1.5

0.39

0.30

nmol/l

0.50

229

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

173

2.21

4.97

1.3

1.4

17.76

12.98

u/l

1.30

165

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

154

2.29

4.96

1.2

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.67

4.92

1.1

0.74

0.67

umol/24h

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.67

4.92

2.8

2.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.23

4.89

1.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

252

1898

1.36

4.88

1.4

1.5

—

(3018333) Ribosomal P Ab [Presence] in Serum

169

2.21

4.81

1.3

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

3.59

4.76

1.3

1.7

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.59

4.76

2.8

2.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.28

4.74

1.1

1.2

—

(21494755) Public health laboratory ask at order entry panel

119

1762

0.66

4.69

1.3

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.85

4.65

1.1

1.2

106.33

91.14

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

212

1566

1.38

4.64

1.4

1.3

76.59

56.65

au/ml

—

128

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.12

4.63

1.3

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

172

2.17

4.62

4.1

2.7

221.16

14.47

mg/l

1.38

125

(3052592) Norovirus Ag [Presence] in Stool

4.30

4.62

2.3

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

237

1784

1.36

4.62

2.5

2.2

11.34

13.50

nmol/l

3.41

210

1627

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

228

1706

1.37

4.61

2.6

2.5

20.34

22.63

au/ml

0.16

167

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

226

2.01

4.60

1.1

—

(3044007) Cell count panel - Peritoneal fluid

2.91

4.60

1.8

1.6

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

173

2.15

4.56

1.3

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

10.02

4.52

1.5

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

221

2.01

4.51

1.2

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

143

2.25

4.40

1.1

8.71

9.38

nmol/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.35

4.32

1.5

1.4

—

(40757373) Influenza virus identified in Isolate

3.35

4.32

1.5

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.79

4.28

1.4

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

114

2.38

4.23

1.9

3.6

27.21

22.58

mu/l

0.20

108

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

249

1.90

4.16

3.0

3.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

344

1.76

4.14

3.3

2.3

32.43

21.68

mg/l

0.87

131

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

103

2.44

4.13

1.1

15.18

249.31

ng/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

225

1712

1.34

4.11

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.87

4.06

1.8

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.63

4.05

1.0

3.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

146

1038

1.43

4.02

1.4

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.94

4.01

1.4

1.1

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

3.90

3.99

2.1

1.4

16.00

5.33

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

105

2.39

3.98

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

165

1205

1.39

3.91

5.4

3.3

1.02

ratio

0.20

154

1090

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

113

2.31

3.85

1.2

1.1

—

(3019174) dRVVT (LA screen)

5.28

3.82

1.4

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

6.02

3.81

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.30

3.81

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2300

22132

1.21

3.79

5.2

4.1

1.45

1.24

mmol/l

30.49

2073

20062

(4268621) Lupus anticoagulant assay

243

1.87

3.79

2.0

2.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

613

1.53

3.75

1.3

142.06

208.67

miu/ml

1.04

276

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.60

3.74

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

303

1.76

3.72

1.1

1.2

117.04

115.12

0.15

272

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

3.01

3.68

1.4

104.60

103.91

0.03

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

3.01

3.68

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

5.01

3.68

1.4

1.2

—

(40768793) Breast Pathology biopsy report

100

675

1.50

3.62

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

4.41

3.62

1.3

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.73

3.59

8.5

7.6

6.13

4.89

kpa

0.67

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

827

7392

1.17

3.41

5.6

5.7

5.08

3.59

ug/l

0.86

748

6673

(3024891) Influenza virus A+B Ag [Presence] in Specimen

580

1.52

3.37

1.1

—

(4195642) Thrombophilia screening test

299

1.72

3.32

1.1

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.65

3.29

1.1

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

123

2.12

3.20

1.7

1.4

2.17

4.85

—

(3006270) Folate [Moles/volume] in Blood

178

1.92

3.19

1.1

389.55

370.29

nmol/l

0.21

156

(3043410) Blood group antigens tested for on Red Blood Cells

2.63

3.13

2.0

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

131

2.07

3.12

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

131

2.07

3.12

1.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

216

1.82

3.09

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

389

3285

1.21

3.06

5.7

4.8

32.21

32.72

0.38

280

2087

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

322

1.66

3.06

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

292

1.69

3.04

1.1

0.97

2.21

eliau/ml

—

123

(3022621) pH of Urine by Test strip

241

1934

1.27

3.03

4.2

2.7

6.01

6.06

0.50

178

1313

(3025018) Bordetella pertussis Ab [Titer] in Serum

147

1.98

2.99

1.3

1.2

—

(3011288) Drugs identified in Urine by Screen method Nominal

418

1.57

2.99

1.9

2.0

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

120

2.09

2.98

1.4

1.2

0.56

0.55

ratio

0.05

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

10.01

2.98

1.0

1.4

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

3.86

2.98

11.6

8.4

0.22

0.43

umol/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.41

2.96

1.1

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.47

2.95

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

280

1.69

2.93

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

206

1.81

2.90

2.0

2.3

13.20

7.06

umol/l

0.37

146

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.38

2.89

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.71

2.88

3.4

1.6

1.24

1.30

umol/l

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

376

1.58

2.84

1.1

1.83

18.29

au/ml

—

(3009871) Measles virus Ab [Titer] in Serum

2.23

2.80

1.7

1.6

4480.00

3920.00

titre

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.47

2.79

2.8

1.8

9.91

1420.53

pmol/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.58

2.78

1.2

1.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

8.35

2.75

1.8

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.72

2.71

1.2

1.1

65.60

79.43

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.72

2.71

1.2

1.1

58.00

70.00

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.40

2.63

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.66

2.62

1.3

1.1

1.19

1.18

mmol/l

0.05

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.34

2.60

1.4

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.34

2.60

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.34

2.60

1.4

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.68

2.59

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

475

1.49

2.57

1.7

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

107

2.06

2.57

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.06

2.56

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

200

1.76

2.56

1.9

2.2

2.17

1.51

u/field

0.54

106

(3016879) Cocaine [Presence] in Urine

559

1.44

2.54

1.7

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.27

2.51

1.4

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.27

2.51

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.98

2.48

1.5

1.6

—

(3027008) Opiates [Presence] in Urine

604

1.42

2.47

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

604

1.42

2.47

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

233

1.68

2.45

5.0

2.6

13.31

11.54

index

0.53

121

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

713

0.64

2.40

1.1

1.56

1.55

g/l

0.09

713

(4212803) Bone marrow aspirate examination

3.34

2.39

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

153

1.84

2.38

1.7

1.4

79.71

78.45

umol/l

0.07

153

(3002619) Bacteria identified in Specimen by Culture

2.42

2.37

1.4

1.2

—

(40758292) HTLV I+II Ab panel - Serum

2.62

2.36

1.6

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.62

2.36

2.7

2.5

5.17

79.69

ug/l

0.49

(3023410) Appearance of Cerebral spinal fluid

222

1.68

2.31

1.4

1.9

—

(3042517) Benzodiazepines panel - Urine

5.56

2.21

1.2

1.1

—

(3028300) Cannabinoids [Presence] in Urine

609

1.39

2.21

1.6

—

(3008898) HLA-B27 [Presence]

100

748

1.35

2.18

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

101

1.99

2.15

1.3

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

181

1.72

2.15

1.2

1.4

—

84.17

—

(3014891) Appearance of Pleural fluid

3.01

2.14

1.4

1.5

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

2.17

2.14

1.6

1.3

56.88

57.02

0.01

(3022689) Creatine [Moles/volume] in Urine

2.37

2.12

2.7

1.3

3.79

7.65

mmol/l

5.08

(3020491) Glucose [Moles/volume] in Blood

168

1.73

2.07

2.3

2.1

6.97

6.55

mmol/l

0.32

107

(3024263) Appearance of Synovial fluid

124

1.86

2.07

1.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.51

2.05

1.0

1.2

1.72

1.99

umol/24h

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

110

1.92

2.05

1.2

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.33

2.04

1.4

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

278

1.56

2.03

1.4

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

125

1.85

2.02

1.1

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.11

2.02

1.2

1.3

38.33

39.20

g/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2378

23225

1.15

2.02

6.0

4.8

1.41

1.50

mmol/l

19.91

2175

21308

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

3.08

2.01

9.1

7.0

10.66

10.22

—

(3024869) Neuronal Ab [Presence] in Serum

2.64

2.00

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

670

0.67

1.99

1.0

1.1

0.60

0.63

ratio

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.03

1.95

1.1

—

(1761868) Lipid panel - Serum or Plasma

804

8697

0.89

1.95

4.0

3.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.98

1.95

1.3

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.55

1.94

2.6

4.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

410

0.58

1.92

1.3

1.6

—

(3027944) Amphetamines [Presence] in Urine

602

1.36

1.88

1.5

1.6

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.65

1.86

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.03

1.85

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

4.17

1.82

1.2

1.0

230.60

304.25

nmol/l

—

(44806071) Cardiolipin IgM antibody measurement

3.05

1.80

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.01

1.80

1.2

1.3

129.56

596.47

ug/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.76

1.79

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

150

1222

1.24

1.76

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.09

1.76

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2390

23400

1.14

1.74

6.0

5.0

4.48

4.69

mmol/l

18.18

2194

21602

(40758358) Immune stain study

3.85

1.71

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

2.19

1.67

4.8

9.1

59.86

71.14

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.16

1.66

2.0

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.59

1.66

1.3

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

418

3745

1.14

1.63

1.6

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.95

1.59

1.1

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.70

1.58

1.3

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.70

1.58

1.0

2.3

—

(4024509) Urine culture

145

1196

1.22

1.55

2.2

1.9

—

(40768443) Skin Pathology biopsy report

140

1154

1.22

1.51

1.3

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

101

1.79

1.48

1.9

2.1

243.14

102.63

ug/min

—

(3035320) C reactive protein [Mass/volume] in Body fluid

178

1.58

1.48

4.0

2.4

37.94

34.30

mg/l

0.17

125

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.37

1.45

1.2

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.13

1.44

1.0

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

3.13

1.44

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.73

1.43

1.0

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

328

1.41

1.43

1.5

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.79

1.43

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2421

23792

1.12

1.38

6.6

5.6

2.57

2.74

mmol/l

17.00

2215

21850

(3038177) Helicobacter pylori Ab [Presence] in Serum

356

1.38

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.94

1.36

1.0

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.89

1.28

2.0

1.5

11.93

8.56

ug/l

1.34

(3047007) Chlamydophila sp Ab [Presence] in Serum

327

1.38

1.28

1.3

1.2

—

(3005033) Fetal Nuchal fold Thickness US

266

0.60

1.24

1.4

1.5

1.32

1.28

—

192

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.34

1.12

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

270

0.63

1.12

1.4

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

136

0.51

1.09

1.3

1.5

164.07

243.26

pmol/l

—

136

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

185

1.46

1.08

1.6

1.2

0.10

1.49

u/ml

1.70

102

(4281824) Cell count and differential, peritoneal fluid

270

1.38

1.06

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

278

0.65

1.06

1.3

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.12

1.05

1.4

2.4

13.16

20.06

umol/l

—

(3033099) Centromere Ab [Titer] in Serum

1.96

1.03

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

2.06

1.03

1.3

1.4

64.86

66.74

ug/l

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.74

1.02

2.9

2.8

32.50

29.07

umol/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

238

0.63

1.00

1.3

1.7

—

(4198724) Urine methamphetamine measurement

1.81

0.98

1.6

1.9

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

498

1.25

0.93

2.2

1.8

203.60

209.66

pmol/l

0.15

475

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.22

0.93

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.72

0.86

1.8

1.4

—

(40768800) Prostate Pathology biopsy report

491

1.23

0.80

1.3

1.2

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

0.79

0.0

6.8

—

8.04

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.79

0.0

3.4

—

45.54

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

585

0.80

0.79

1.3

1.6

1156.77

979.87

mu/l

0.33

480

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

327

0.73

0.78

1.3

1.5

1.03

1.22

ratio

0.59

209

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

327

0.73

0.78

1.3

1.5

0.99

0.96

ratio

0.12

209

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

327

0.73

0.78

1.3

1.5

1.69

1.11

ratio

0.45

209

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.59

0.78

1.0

1.3

0.35

0.29

g/l

2.23

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.09

0.74

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

323

0.74

0.73

1.3

1.5

—

(4034850) Laboratory test

774

1.17

0.72

14.3

9.6

—

(3020650) Glucose [Presence] in Urine

100

1.50

0.72

2.1

2.0

0.00

0.03

estimate

0.50

100

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.00

0.72

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

238

1.31

0.70

1.2

1.3

7.64

7.47

mmol/l

0.15

212

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.56

0.68

1.0

1.3

123.08

106.76

1.43

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.85

0.68

1.2

1.1

0.02

u/ml

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.54

0.65

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.54

0.65

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.54

0.65

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.54

0.65

1.2

1.1

—

(1002224) Polysomnography panel

107

947

1.13

0.61

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.60

0.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.72

0.57

1.0

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.67

0.56

1.7

1.1

106.50

93.53

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

195

0.72

0.56

1.1

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

185

1.30

0.56

1.0

877.33

707.39

ng/l

0.65

114

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.62

0.55

1.8

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.62

0.55

1.7

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

785

1.14

0.55

2.1

1.7

5.39

4.50

mg/l

0.25

578

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

194

0.72

0.54

1.1

1.6

60.11

55.00

ug/l

0.19

194

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

116

1.38

0.54

1.2

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

350

0.80

0.54

1.3

1.5

78.47

60.28

ug/l

0.49

290

(3051387) C reactive protein [Mass/volume] in Capillary blood

488

1.17

0.53

5.6

3.4

27.32

26.82

mg/l

0.03

328

(3036071) Salmonella sp Ab [Titer] in Serum

1.45

0.53

1.1

1.0

—

(4015189) Microbial culture of sputum

1.41

0.51

1.9

2.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

188

1.28

0.51

1.0

36.80

45.61

ng/l

0.94

119

(3006462) Nitrate [Presence] in Urine

118

1.36

0.50

5.4

3.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

832

0.89

0.45

1.5

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

113

1.33

0.42

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.43

0.42

1.1

1.0

0.29

2.04

u/ml

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

273

0.80

0.42

1.4

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

360

0.83

0.42

1.1

2.09

1.29

u/ml

0.22

195

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

12.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.80

—

(1617658) Protocol used for examination of sentinel lymph nodes

222

1.22

0.41

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.40

0.0

1.2

—

6.11

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

634

1.12

0.40

2.1

1.8

38.96

42.59

nmol/l

0.63

613

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

186

1.24

0.40

1.0

390.41

335.18

ng/l

0.34

119

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.34

0.39

1.1

9.80

7.01

u/ml

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

378

0.84

0.39

1.1

2.75

4.13

u/ml

0.37

210

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.39

0.38

1.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.34

0.38

1.4

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

113

0.71

0.37

1.8

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1915

19356

0.97

0.36

46.5

19.5

329.80

331.84

g/l

18.09

1908

19234

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.30

0.33

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

350

3635

0.96

0.31

1.4

1.5

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.73

0.30

1.1

1.2

18.14

10.76

mm/h

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

260

0.84

0.29

1.1

0.04

0.31

u/ml

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

366

0.87

0.29

1.1

0.80

1.42

u/ml

0.37

174

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

173

1822

0.95

0.28

2.3

2.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

608

5932

1.03

0.28

4.6

22.43

21.71

0.49

337

3081

(4211845) Urine protein measurement

131

1.22

0.27

5.4

3.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

800

0.92

0.26

1.5

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

151

1.19

0.25

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.01

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

997

0.94

0.21

1.5

1.9

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

436

4464

0.97

0.20

3.3

0.96

0.78

ug/l

1.10

317

2992

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

197

2045

0.96

0.20

1.4

—

(4133840) Spirometry

1.18

0.19

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1020

0.95

0.18

1.8

1.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.22

0.17

1.9

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

159

1649

0.96

0.17

2.2

1.9

—

(3029075) Extractable nuclear Ab panel - Serum

148

1.15

0.17

1.2

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1032

10212

1.02

0.15

2.2

1.9

1.47

1.31

mmol/l

5.91

861

8405

(3003740) Influenza virus B Ag [Presence] in Specimen

380

1.08

0.15

1.2

1.1

—

(44813793) Dust mix specific IgE antibody measurement

159

0.88

0.13

1.1

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.17

0.13

4.2

2.1

16.76

104.08

ug/l

0.54

(3014133) Dog dander IgE Ab [Units/volume] in Serum

302

0.93

0.11

1.1

1.02

2.98

u/ml

1.72

148

(3025130) Human papilloma virus identified in Specimen

331

0.94

0.10

1.3

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

379

1.06

0.09

1.2

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.04

0.09

1.4

2.2

7.98

7.99

mmol/l

—

(3025577) Chromium [Mass/volume] in Blood

175

1.09

0.08

1.9

2.1

2.33

2.00

ug/l

0.32

147

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

144

0.90

0.08

1.3

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

714

0.97

0.08

1.4

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

399

0.95

0.08

1.3

1.5

—

(3034426) Prothrombin time (PT)

1.04

0.08

1.1

1.3

28.57

27.74

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

215

0.93

0.07

1.3

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

650

1.03

0.06

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

182

1.04

0.02

1.9

1.7

1.82

4.87

ug/l

1.25

149

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

452

1.02

0.01

1.1

0.74

1.60

u/ml

1.51

258

(3023430) Cat dander IgE Ab [Units/volume] in Serum

277

0.97

0.01

1.1

1.01

4.82

u/ml

2.26

124

(44806420) Estimation of glomerular filtration rate

252

0.99

0.00

3.4

2.4

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.40

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.00

0.00

1.0

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

1.01

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.89

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

276.44

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.7

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_CA_MET – Disorders of calcium metabolism

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Disorders of calcium metabolism

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Disorders of calcium metabolism (E4_CA_MET)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints